LIFE, ACCIDENT AND HEALTH, Series 4-2 Accident and Health (General)

ColoradoRegulations

Ask Donna

How this section applies to your facts.

Code of Colorado Regulations › 700 Department of Regulatory Agencies › 702 Division of Insurance › 3 CCR 702-4 Series 4-2

This text was captured on Sep 30, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

Regulation 4-2-1

REPLACEMENT OF INDIVIDUAL ACCIDENT AND SICKNESS

INSURANCE

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Rules

Section 6

Additional Rules for the Replacement of Health Benefit Plans

Section 7

Incorporation by Reference

Section 8

Severability

Section 9

Enforcement

Section 10

Effective Date

Section 11

History

Appendix A Notice to Applicant Regarding Replacement of Accident and Sickness

Insurance

Appendix B Notice to Applicant Regarding Replacement of a Health Benefit Plan

Section 1

Authority

This amended regulation is promulgated and adopted by the Commissioner of

Insurance under the authority of §§ 10-1-109, 10-3-1110, and 10-16-109, C.R.S.

Section 2

Scope and Purpose

The purpose of this regulation is to reduce the opportunity for misrepresentation and

other unfair practices and methods of competition in the business of insurance. The

scope of this regulation includes persons covered by an individual health care coverage

plan offered by a health maintenance organization and individual accident and sickness

insurance policies or plans, who are considering replacement of their coverage.

Section 3

Applicability

This regulation shall apply to individual accident and sickness insurance policies and all

service or indemnity contracts offered by entities subject to Part 2, Part 3 and Part 4 of

Article 16 of Title 10, except conversion to an individual or family policy from a group,

blanket or group type policy, or any other insurance that is covered by a separate state

statute.

Section 4

Definitions

A.

“Accident and sickness insurance” means, for the purposes of this regulation, a

policy, plan, contract, agreement, statement of coverage, rider or endorsement

that provides accident or sickness benefits or medical, surgical or hospital

benefits, whether on an indemnity, reimbursement, service or prepaid basis,

except when issued in connection with another kind of insurance other than life

and except disability, waiver of premium and double indemnity benefits included

in life insurance and annuity contracts. For the purposes of this regulation,

accident and sickness insurance includes health coverage plans.

B.

“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S.

C.

“Direct response” means, for the purposes of this regulation, a solicitation

through a sponsoring or endorsing entity or individually, solely through mail,

telephone, the internet, or other mass communication media.

D.

“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),

C.R.S.

E.

“Health coverage plan” shall have the same meaning as found at § 10-16-

102(34), C.R.S.

Section 5

Rules

A.

Application forms shall include the following questions designed to elicit

information as to whether, as of the date of the application, the applicant has an

accident and sickness insurance policy or health coverage plan in force, or

whether an accident and sickness insurance policy or health coverage plan is

intended to replace or be in addition to any other accident and sickness

insurance policy or health coverage plan presently in force. A supplementary

application or other form to be signed by the applicant and producer containing

such questions and statements may be used.

1.

Statements

a.

You normally do not require more than one of the same type of

policy.

b.

If you purchase this policy, you may want to evaluate your existing

health insurance and decide if you need multiple coverages.

c.

You may be eligible for benefits under Medicaid or Medicare and

may not need another health insurance policy. If you are eligible for

Medicare, you may want to purchase a Medicare supplement

insurance policy.

d.

If you are eligible for Medicare due to age or disability, counseling

services are available in Colorado to provide advice concerning

your purchase of Medicare supplement insurance and concerning

medical assistance through the state Medicaid program, Health

First Colorado.

2.

Questions

To the best of your knowledge:

a.

Do you have another health insurance policy or contract in force?

(1)

If so, with which company?

(2)

If so, do you intend to replace your current health insurance

policy or contract with this policy?

b.

Do you have any other health insurance that provides benefits

similar to this accident and sickness policy?

(1)

If so, with which company?

(2)

What kind of policy?

c.

Are you covered for medical assistance through the state Medicaid

program, Health First Colorado:

(1)

As a Specified Low-Income Medicare Beneficiary (SLMB)?

(2)

As a Qualified Medicare Beneficiary (QMB)?

(3)

For other Medicaid medical benefits?

B.

Producers must list all other accident and sickness insurance policies or

contracts they have sold to the applicant.

1.

List policies and/or contracts sold which are still in force; and

2.

List policies and/or contracts sold in the past five (5) years which are no

longer in force.

C.

In the case of a direct response carrier, a copy of the application or supplemental

form, signed by the applicant, and acknowledged by the carrier, shall be returned

to the applicant by the carrier upon delivery of the policy.

D.

Delivery of Replacement Notice

1.

Upon determining that a sale will involve replacement of an accident and

sickness insurance policy or health coverage plan, a carrier, other than a

direct response carrier, or its producer, shall furnish the applicant, prior to

issuance or delivery of the accident and sickness insurance policy or

health coverage plan, a notice regarding replacement of accident and

sickness insurance. One (1) copy of such notice signed by the applicant

and producer, except where the coverage is sold without a producer, shall

be provided to the applicant and an additional signed copy shall be

retained by the carrier.

2.

A direct response carrier shall deliver to the applicant, at the time of

issuance of the policy, the appropriate notice, located in Appendix A or B

of this regulation.

E.

The notices required by subsection 5.D. must be provided in the format

prescribed and adopted by the Commissioner of Insurance and are provided in

Appendices A and B of this regulation.

F.

Paragraph 1. of the notices provided in Appendices A and B, may be deleted by

the carrier if the replacement does not involve the application of a new pre-

existing condition limitation.

G.

Failure to comply with the requirements of this section 5 constitutes an unfair

method of competition and an unfair or deceptive act or practice in the business

of insurance which is prohibited under § 10-3-1104, C.R.S.

Section 6

Additional Rules for the Replacement of Health Benefit Plans

A.

Carriers are not required to provide the notice in Appendix B when an applicant is

replacing his or her current individual health benefit plan with another individual

health benefit plan during the annual open enrollment period or if the

replacement is due to eligibility for a special enrollment due to one or more of the

triggering events listed in Colorado Insurance Regulation 4-2-43.

B.

Carriers are required to provide the notice in Appendix B when an applicant is

replacing his or her current individual health benefit plan with an accident and

sickness insurance policy or health coverage plan which does not meet the

definition of a health benefit plan.

Section 7

Incorporation by Reference

Colorado Insurance Regulation 4-2-43, 3 CCR 702-4 published by the Colorado

Division of Insurance shall mean Colorado Insurance Regulation 4-2-43, 3 CCR 702-4

as published on the effective date of this regulation and does not include later

amendments to, or editions of, Colorado Insurance Regulation 4-2-43, 3 CCR 702-4.

Colorado Insurance Regulation 4-2-43, 3 CCR 702-4 may be examined during regular

business hours at the Colorado Division of Insurance, 1560 Broadway, Suite 850,

Denver, Colorado 80202 or by visiting the Colorado Division of Insurance website at

www.dora.colorado.gov/insurance. Certified copies of Colorado Insurance Regulation 4-

2-43, 3 CCR 702-4 are available from the Division of Insurance for a fee.

Section 8

Severability

If any provision of this regulation or the application of it to any person or circumstances

is for any reason held to be invalid, the remainder of this regulation shall not be

affected.

Section 9

Enforcement

Noncompliance with this regulation may result in the imposition of any of the sanctions

made available in the Colorado statutes pertaining to the business of insurance, or other

laws, which include the imposition of civil penalties, issuance of cease and desist

orders, and/or suspensions or revocation of license, subject to the requirements of due

process.

Section 10 Effective Date

This regulation is effective April 1, 2018.

Section 11 History

Originally issued as Regulation 74-2, effective March 15, 1974.

Amended December 22, 1975, effective January 1, 1976.

Amended effective January 14, 1977.

Renumbered on June 1, 1992.

Repealed and Repromulgated in full, effective February 1, 2001.

Amended Regulation 4-2-1, effective May 1, 2010.

Amended Regulation effective November 1, 2013.

Amended Regulation effective April 1, 2018.

Appendix A

NOTICE TO APPLICANT

REGARDING REPLACEMENT OF

ACCIDENT AND SICKNESS INSURANCE

[Carrier Name and Address]

According to [your application] [the information furnished by you], you intend to lapse or

otherwise terminate your present policy and replace it with a policy to be issued by

[carrier name]. [Your new policy will provide [number of days of the free look period]

days within which you may decide without cost whether you want to keep the policy.]

You should review this new coverage carefully. Compare it with all accident and

sickness coverage you now have. If, after due consideration, you find the purchase of

this accident and sickness coverage is a wise decision, you should evaluate the need

for other accident and sickness coverage you have that may duplicate this policy.

STATEMENT TO APPLICANT BY CARRIER OR PRODUCER:

I have reviewed your current health coverage. To the best of my knowledge, this

accident and sickness policy will not duplicate your existing coverage because you

intend to terminate your existing coverage. The replacement policy is being purchased

for the following reason(s)(check one):

______

Additional benefits

______

No change in benefits, but lower premiums

______

Fewer benefits and lower premiums

______

Other. (Please specify.)

1.

Health conditions which you may presently have (pre-existing conditions) may

not be immediately or fully covered under the new policy. This could result in the

denial or delay of a claim for benefits under the new policy, whereas a similar

claim may have been payable under your present policy.

2.

If you wish to terminate your present policy and replace it with new coverage, be

certain to truthfully and completely answer all questions on the application

concerning your medical and health history. Failure to include all material medical

information on an application may provide a basis for the company to deny any

future claims and to refund your premium as though your policy had never been

in force. After the application has been completed and before you sign it, review it

carefully to be certain that all information has been properly recorded. [If the

policy or contract is guaranteed issued this paragraph need not appear.]

Do not cancel your current policy until you have received your new policy and are sure

that you want to keep it.

_________________________________________

(Signature of Producer or Other Representative) *

[Typed Name and Address of Carrier, Producer, or Other Representative]

[_________________________________________

(Carrier Acknowledgement of Receipt and Review) **

_________________________________________]

(Date)

_________________________________________

(Applicant’s Signature)

_________________________________________

(Date)

* Signature not required for direct response sales.

** For use by direct response carriers.

Appendix B

NOTICE TO APPLICANT

REGARDING REPLACEMENT OF A HEALTH BENEFIT PLAN

[Carrier Name and Address]

According to [your application] [the information furnished by you], you intend to lapse or

otherwise terminate your present policy and replace it with a policy to be issued by

[carrier name]. [Your new policy will provide [number days of free look period] days

within which you may decide without cost whether you want to keep the policy.]

You should review this new coverage carefully. Compare it with all accident and

sickness coverage you now have. If, after due consideration, you find the purchase of

this accident and sickness coverage is a wise decision, you should evaluate the need

for other accident and sickness coverage you have that may duplicate this policy.

STATEMENT TO APPLICANT BY CARRIER OR PRODUCER:

I have reviewed your current accident and sickness insurance coverage, which provides

comprehensive medical coverage. To the best of my knowledge, this accident and

sickness policy will not duplicate your existing coverage because you intend to

terminate your existing coverage. The replacement policy is being purchased for the

following reason(s)(check one):

______

Additional benefits

______

No change in benefits, but lower premiums

______

Fewer benefits and lower premiums

______

Other. (Please specify.)

1.

Health conditions which you may presently have (pre-existing conditions) may

not be immediately or fully covered under the new policy. This could result in the

denial or delay of a claim for benefits under the new policy, whereas a similar

claim may have been payable under your present policy, which provides

comprehensive coverage.

2.

If you wish to terminate your present policy and replace it with new coverage, be

certain to truthfully and completely answer all questions on the application

concerning your medical and health history. Failure to include all material medical

information on an application may provide a basis for the company to deny any

future claims and to refund your premium as though your policy had never been

in force. After the application has been completed and before you sign it, review it

carefully to be certain that all information has been properly recorded. [If the

policy or contract is guaranteed issued this paragraph need not appear.]

Do not cancel your current policy until you have received your new policy and are sure

that you want to keep it.

________________________________________

(Signature of Producer or Other Representative) *

[Typed Name and Address of Carrier, Producer, or Other Representative]

[_________________________________________

(Carrier Acknowledgement of Receipt and Review) **

_________________________________________]

(Date)

__________________________________________

(Applicant’s Signature)

___________________________________________

(Date)

* Signature not required for direct response sales.

** For use by direct response carriers.

Regulation 4-2-2

HOSPITAL INDEMNITY AND DISABILITY INCOME POLICIES

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Rules

Section 6

Severability

Section 7

Enforcement

Section 8

Effective Date

Section 9

History

Section 1

Authority

This regulation is promulgated and adopted by the Commissioner of Insurance under

the authority of § § 10-1-109 and 10-16-109, C.R.S.

Section 2

Scope and Purpose

This regulation prohibits insurers from refusing to pay benefits under certain contracts

because of hospitalization in government hospitals.

Section 3

Applicability

This regulation applies to all hospital indemnity and disability income policies, contracts,

riders, endorsements, etc., which provide benefits because of hospitalization or

disability originating out of hospitalization hereinafter referred to as hospital indemnity

and disability income policies. It does not apply to hospital expense policies.

Section 4

Definitions

For the purposes of this regulation:

A.

“Disability income policy” means, for the purposes of this regulation, a policy that

provides periodic payments to replace income lost when the insured is unable to

work as the result of a sickness or injury.

B.

“Government hospital” means, for the purposes of this regulation, any hospital

under governmental control whether federal, state, county or city. It includes

Veterans Administration hospitals.

C.

“Hospital indemnity policy” means, for the purposes of this regulation, a policy

that provides a stated daily, weekly or monthly payment while the insured is

hospitalized, regardless of expenses incurred and regardless of whether or not

other insurance is in force. The insured can use the daily, weekly or monthly

benefit as he or she chooses, for hospital or other expenses.

Section 5

Rules

All hospital indemnity and disability income policies delivered or issued for delivery in

the State of Colorado which provide benefits predicated on hospitalization will not in any

way deny such benefits on the basis that such hospitalization was in a government

hospital.

Section 6

Severability

If any provision of this regulation or the application of it to any person or circumstance is

for any reason held to be invalid, the remainder of the regulation shall not be affected.

Section 7

Enforcement

Noncompliance with this regulation may result in the imposition of any of the sanctions

made available in the Colorado statutes pertaining to the business of insurance, or other

laws, which include the imposition of civil penalties, issuance of cease and desist

orders, and/or suspension or revocation of license, subject to the requirements of due

process.

Section 8

Effective Date

This regulation shall be effective December 1, 2013.

Section 9

History

Originally issued as Regulation 74-4, effective July 1, 1974.

Renumbered as Regulation 4-2-2, effective June 1, 1992.

Repealed and Repromulgated in full, effective January 1, 2001.

Amended Regulation 4-2-2, effective July 1, 2010.

Amended Regulation 4-2-2, effective December 1, 2013.

Regulation 4-2-3

ADVERTISEMENTS OF ACCIDENT AND SICKNESS

INSURANCE

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Method of Disclosure of Required Information

Section 6

Format and Content of Advertisements

Section 7

Advertisement of Benefits Payable, Losses Covered or Premiums Payable

Section 8

Necessity for Disclosing Policy Provisions Relating to Renewability,

Cancellability and Termination

Section 9

Standards for Marketing

Section 10

Testimonials or Endorsements by Third Parties

Section 11

Use of Statistics

Section 12

Identification of Plan or Number of Policies

Section 13

Disparaging Comparisons and Statements

Section 14

Jurisdictional Licensing and Status of Insurer

Section 15

Identity of Insurer

Section 16

Group or Quasi-Group Implications

Section 17

Introductory, Initial or Special Offers

Section 18

Statements about an Insurer

Section 19

Enforcement Procedures

Section 20

Severability

Section 21

Incorporated Materials

Section 22

Enforcement

Section 23

Effective Date

Section 24

History

Section 1

Authority

This regulation is promulgated under the authority of §§ 10-1-109 and 10-3-1110, C.R.S.

Section 2

Scope and Purpose

The purpose of this regulation is to establish minimum criteria to assure proper and

accurate description and to protect prospective purchasers with respect to the

advertisement of accident and sickness insurance. This regulation assures the clear

and truthful disclosure of the benefits, limitations and exclusions of policies sold as

accident and sickness insurance by the establishment of standards of conduct in the

advertising of accident and sickness insurance in a manner that prevents unfair,

deceptive and misleading advertising and is conducive to accurate presentation and

description to the insurance-buying public through the advertising media and material

used by insurance producers and companies.

Section 3

Applicability

A.

This regulation shall apply to any accident and sickness insurance

“advertisement”, as that term is defined, intended for presentation, distribution or

dissemination in Colorado when such presentation, distribution or dissemination

is made either directly or indirectly by or on behalf of an insurer or producer, as

those terms are defined in the Colorado Revised Statutes and this regulation.

B.

Every insurer shall establish and at all times maintain a system of control over

the content, form and method of dissemination of all advertisements of its

policies. All of the insurer's advertisements, regardless of by whom written,

created, designed or presented, shall be the responsibility of the insurer whose

policies are advertised.

C.

Advertising materials that are reproduced in quantity shall be identified by form

numbers or other identifying means. The identification shall be sufficient to

distinguish an advertisement from any other advertising materials, policies,

applications or other materials used by the insurer.

Section 4

Definitions

A.

“ACA” means, for the purposes of this regulation, the Patient Protection and

Affordable Care Act, Pub. L. 111-148 and the Health Care and Education

Reconciliation Act of 2010, Pub. L. 111-152.

B.

“Accident and sickness insurance policy” means, for the purposes of this

regulation, a policy, plan, certificate, contract, agreement, statement of coverage,

rider or endorsement that provides accident or sickness benefits or medical,

surgical or hospital benefits, whether on an indemnity, reimbursement, service or

prepaid basis, except when issued in connection with another kind of insurance

other than life and except disability, waiver of premium and double indemnity

benefits included in life insurance and annuity contracts.

1.

An accident and sickness insurance policy does not include a Medicare

supplement insurance policy or any other type of accident and sickness

insurance with advertising guidelines covered by a separate statute and/or

regulation.

2.

The language “except disability, waiver of premium and double indemnity

benefits included in life insurance and annuity contracts” means it does

not include disability, waiver of premium and double indemnity benefits

included in life insurance, endowment or annuity contracts or contracts

supplemental to the above contracts that contain only provisions that:

a.

Provide additional benefits in case of death or dismemberment or

loss of sight by accident; or

b.

Operate to safeguard the contracts against lapse or to give a

special surrender value, special benefit or an annuity in the event

that the insured or annuitant becomes totally and permanently

disabled as defined by the contract or supplemental contract.

C.

“Advertisement” means, for the purposes of this regulation, printed and published

material, audio visual material, and descriptive literature of an insurer used in

direct mail, newspapers, magazines, radio scripts, TV scripts, web sites and

other Internet displays or communications, other forms of electronic

communications, billboards and similar displays.

1.

“Advertisement” also means:

a.

Descriptive literature and sales aids of all kinds issued by an

insurer or producer for presentation to members of the insurance-

buying public, such as circulars, leaflets, booklets, depictions,

illustrations, form letters and lead-generating devices of all kinds;

b.

Digital advertisements such as any advertisement delivered

through electronic means including email, text message, social

media, mobile applications, search engines, websites, web-based

platforms, chat interfaces, or automated electronic communication

tools.

c.

Prepared sales talks, presentations and material for use by

producers whether prepared by the insurer or producer;

d

Summary of Benefits and Coverage (SBC) forms; and

e.

The Colorado Supplement to the Summary of Benefits and

Coverage Form as found in Colorado Insurance Regulation 4-2-20.

2.

The definition of “advertisement” includes advertising material included

with a policy when the policy is delivered and material used in the

solicitation of renewals and reinstatements.

3.

The definition of “advertisement” extends to the use of all media for

communications to the general public; to the use of all media for

communications to specific members of the general public; and to the use

of all media for communications by insurers or producers.

4.

The definition of “advertisement” does not include:

a.

Material used solely for the training and education of an insurer’s

employees or producers;

b.

Material used in-house by insurers;

c.

Communications within an insurer’s own organization not intended

for dissemination to the public;

d.

Individual communications of a personal nature with current

policyholders other than material urging the policyholders to

increase or expand coverages;

e.

Correspondence between a prospective group or blanket

policyholder and an insurer in the course of negotiating a group or

blanket contract;

f.

Court-approved material ordered by a court to be disseminated to

policyholders; or

g.

A general announcement from a group or blanket policyholder to

eligible individuals on an employment or membership list that a

contract or program has been written or arranged, provided that the

announcement clearly indicates that it is preliminary to the issuance

of a booklet and that the announcement does not describe the

specific benefits under the contract or program nor describe

advantages as to the purchase of the contract or program. This

does not prohibit a general endorsement of the program by the

sponsor.

D.

“Certificate” means, for the purposes of this regulation, a statement of the

coverage and provisions of a group accident and sickness insurance policy,

which has been delivered or issued for delivery in this state and includes riders,

endorsements and enrollment forms, if attached.

E.

“Exception” means, for the purposes of this regulation, any provision in a policy

whereby coverage for a specified hazard is entirely eliminated; it is a statement

of a risk not assumed under the policy.

F.

“Format” means, for the purposes of this regulation, the arrangement of the text

and the captions.

G.

“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),

C.R.S.

H.

“Health coverage plan” shall have the same meaning as found at § 10-16-

102(34), C.R.S.

I.

“Institutional advertisement” means, for the purposes of this regulation, an

advertisement having as its sole purpose the promotion of the reader’s, viewer’s

or listener’s interest in the concept of accident and sickness insurance, or the

promotion of the insurer as a seller of accident and sickness insurance. Insurers

are required to comply with section 15.A. of the regulation, clearly identifying the

name of the insurer.

J.

“Insurer” shall have the same meaning as “carrier” as found at § 10-16-102(8),

C.R.S., and applies to any carrier subject to Title 10, Article 16, Parts 2, 3 or 4.

K.

“Invitation to contract” means, for the purposes of this regulation, an

advertisement that is neither an “invitation to inquire” nor an “institutional

advertisement”.

L.

“Invitation to inquire” means, for the purposes of this regulation, an advertisement

having as its objective the creation of a desire to inquire further about accident

and sickness insurance and that is limited to a brief description of the loss for

which benefits are payable, but may contain the dollar amount of benefits

payable and the period of time during which benefits are payable.

1.

An “invitation to inquire” shall not refer to cost.

2.

An “invitation to inquire” shall contain a provision in the following or

substantially similar form:

“This policy has [exclusions] [limitations] [reduction of benefits] [terms

under which the policy may be continued in force or discontinued]. For

costs and complete details of the coverage, call [or write] your insurance

producer or the company [whichever is applicable].”

M.

“Juxtaposition” means, for the purposes of this regulation, side-by-side or

immediately above or below.

N.

“Lead-generating device” means, for the purposes of this regulation, any

communication directed to the public that, regardless of form, content or stated

purpose is intended to result in the compilation or qualification of a list containing

names and other personal information to be used to solicit residents of this state

for the purchase of accident and sickness insurance.

O.

“Limitation” means, for the purposes of this regulation, a provision that restricts

coverage under the policy other than an exception or a reduction.

P.

“Limited benefit health coverage” means, for the purposes of this regulation, any

type of health coverage that is not provided by a health benefit plan, as found at

§ 10-16-102(32), C.R.S.

This subsection does not apply to policies designed to provide coverage for long-

term care or to Medicare supplement insurance.

Q.

“Marketing” means, for the purposes of this regulation, any activity or effort

directed toward the public which is intended to promote or sell products or

services.

R.

“Prominently” or “conspicuously” means, for the purposes of this regulation, that

the information to be disclosed “prominently” or “conspicuously” shall be

presented in a manner that is noticeably set apart from other information or

images in the advertisement.

S.

“Reduction” means, for the purposes of this regulation, a provision that reduces

the amount of the benefit; a risk of loss is assumed but payment upon the

occurrence of the loss is limited to some amount or period less than would be

otherwise payable had the reduction not been used.

T.

“Short-term limited duration health insurance policy” shall have the same

meaning as found at § 10-16-102(60), C.R.S.

U.

“Summary of Benefits and Coverage” or “SBC” means, for the purposes of this

regulation, the form required by 45 C.F.R. § 147.200(a).

Section 5

Method of Disclosure of Required Information

All information, exceptions, limitations, reductions and other restrictions required to be

disclosed by this regulation shall be set out conspicuously and in close conjunction to

the statements to which the information relates or under appropriate captions of such

prominence that it shall not be minimized, rendered obscure or presented in an

ambiguous fashion or intermingled with the context of the advertisements so as to be

confusing or misleading. This regulation permits, but is not limited to, the use of either of

the following methods of disclosure:

A.

Disclosure in the description of the related benefits or in a paragraph set out in

close conjunction with the description of policy benefits; or

B.

Disclosure not in conjunction with the provisions describing policy benefits but

under appropriate captions of such prominence that the information shall not be

minimized, rendered obscure or otherwise made to appear unimportant. The

phrase “under appropriate captions” means that the title must be accurately

descriptive of the captioned material. Appropriate captions include the following:

“Exceptions”, “Exclusions”, “Conditions Not Covered”, and “Exceptions and

Reductions”. The use of captions such as the following are prohibited because

they do not provide adequate notice of the significance of the material: “Extent of

Coverage”, “Only these Exclusions”, or “Minimum Limitations”.

Section 6

Format and Content of Advertisements

A.

The format and content of an advertisement of an accident and sickness

insurance policy shall be sufficiently complete and clear to avoid deception or the

capacity or tendency to mislead or deceive.

B.

Distinctly different advertisements are required for publication in different media,

such as newspapers or magazines of general circulation as compared to

scholarly, technical or business journals and newspapers. Where an

advertisement consists of more than one piece of material, each piece of material

must, independent of all other pieces of material, conform to the disclosure

requirements of this regulation.

C.

Whether an advertisement has a capacity or tendency to mislead or deceive shall

be determined by the Commissioner from the overall impression that the

advertisement may be reasonably expected to create within the segment of the

public to which it is directed.

D.

Advertisements shall be truthful and not misleading in fact or implication. Words

or phrases, the meaning of which is clear only by implication or by familiarity with

insurance terminology, shall not be used.

E.

An insurer shall clearly identify its accident and sickness insurance policy as an

insurance policy. A policy trade name shall be followed by the words “insurance

policy” or similar words clearly identifying the fact that an insurance policy or

health benefits product (in the case of health maintenance organizations, prepaid

health plans and other direct service organizations) is being offered.

F.

An insurer, producer or other person shall not solicit a resident of this state for

the purchase of accident and sickness insurance in connection with or as the

result of the use of an advertisement by the person or any other persons, where

the advertisement:

1.

Contains any misleading representations or misrepresentations, or is

otherwise untrue, deceptive or misleading with regard to the information

imparted, the status, character or representative capacity of the person or

the true purpose of the advertisement; or

2.

Otherwise violates the provisions of this regulation.

G.

An insurer, producer or other person shall not solicit residents of this state for the

purchase of accident and sickness insurance through the use of a true or

fictitious name that is deceptive or misleading with regard to the status, character

or proprietary or representative capacity of the person or the true purpose of the

advertisement.

H.

An insurer is prohibited from representing or naming any health coverage plan as

a Bronze, Silver, Gold, or Platinum metal tier level of coverage unless that policy

is a health benefit plan as specified in § 10-16-103.4, C.R.S. Use of these terms

for a non-ACA compliant health coverage plan may be found to violate § 10-3-

1104(1)(a)(V), C.R.S. This prohibition also applies to short-term limited duration

health insurance policies.

I.

An insurer, producer, or other person is prohibited from advertising any health

coverage plan which is not ACA-compliant as an alternative to, equivalent to, or a

substitute for, a health benefit plan which meets federal and state requirements

under the ACA.

Section 7

Advertisements of Benefits Payable, Losses Covered or Premiums

Payable

A.

Covered Benefits

1.

The use of deceptive words, phrases or illustrations in advertisements of

accident and sickness insurance is prohibited.

2.

An advertisement that fails to state clearly the type of insurance coverage

being offered is prohibited.

3.

An advertisement shall not omit information or use words, phrases,

statements, references or illustrations if the omission of information or use

of words, phrases, statements, references or illustrations has the capacity,

tendency or effect of misleading or deceiving purchasers or prospective

purchasers as to the nature or extent of any policy benefit payable, loss

covered or premium payable. The fact that the policy offered is made

available to a prospective insured for inspection prior to consummation of

the sale or an offer is made to refund the premium if the purchaser is not

satisfied, does not remedy misleading statements.

4.

An advertisement shall not contain or use words or phrases such as “all”,

“full”, “complete”, “comprehensive”, “unlimited”, “up to”, “as high as”, “this

policy will help fill some of the gaps that Medicare and your present

insurance leave out”, “the policy will help to replace your income” (when

used to express loss of time benefits), or similar words and phrases, in a

manner that exaggerates a benefit beyond the terms of the policy.

5.

An advertisement of a hospital or other similar facility confinement benefit

that makes reference to the benefit being paid directly to the policyholder

is prohibited unless, in making the reference, the advertisement includes a

statement that the benefits may be paid directly to the hospital or other

health care facility if an assignment of benefits is made by the

policyholder. An advertisement of medical and surgical expense benefits

shall comply with this regulation in regard to the disclosure of assignments

of benefits to providers of services. Phrases such as “you collect”, “you get

paid”, “pays you”, or other words or phrases of similar import may be used

so long as the advertisement indicates that it is payable to the insured or

someone designated by the insured.

6.

An advertisement for basic hospital expense coverage, basic medical-

surgical expense coverage, basic hospital/medical-surgical expense

coverage, hospital confinement indemnity coverage, accident-only

coverage, specified disease coverage, specified accident coverage,

limited benefit health coverage or for coverage that covers only a certain

type of loss is prohibited if:

a.

The advertisement refers to a total benefit maximum limit payable

under the policy in any headline, lead-in or caption without, also in

the same headline, a lead-in or caption specifying the applicable

daily limits and other internal limits;

b.

The advertisement states a total benefit limit without stating the

periodic benefit payment, if any, and the length of time the periodic

benefit would be payable to reach the total benefit limit; or

c.

The advertisement prominently displays a total benefit limit that

would not, as a general rule, be payable under an average claim.

Section 7.A.6. does not apply to individual health benefit plans or disability

income insurance.

7.

Advertisements that emphasize total amounts payable under hospital,

medical or surgical accident and sickness insurance coverage or other

benefits in a policy, such as benefits for private duty nursing, are

prohibited unless the actual amounts payable per day for the indemnity or

benefits are stated.

8.

Advertisements that include examples of benefits payable under a policy

shall not use examples in a way that implies that the maximum benefit

payable under the policy will be paid, when less than maximum benefits

are paid for an average claim.

9.

When a range of benefit levels is set forth in an advertisement, it shall be

clear that the insured will receive only the benefit level written or printed in

the policy selected and issued. Language that implies that the insured

may select the benefit level at the time of filing claims is prohibited.

10.

Language in an advertisement that implies that the amount of benefits

payable under a loss-of-time policy may be increased at the time of claim

or disability according to the needs of the insured is prohibited.

11.

Advertisements for policies with premiums that are modest because of

their limited coverage or limited amount of benefits shall not describe

premiums as “low”, “low cost”, “budget” or use qualifying words of similar

import. The use of words such as “only” and “just” in conjunction with

statements of premium amounts when used to imply a bargain are

prohibited.

12.

Advertisements that state or imply that premiums will not be changed in

the future are prohibited unless the advertised policies expressly provide

that the premiums will not be changed in the future.

13.

An advertisement for a policy that does not require the premium to

accompany the application shall not overemphasize that fact and shall

clearly indicate under what circumstances coverage will become effective.

14.

An advertisement that exaggerates the effects of statutorily-mandated

benefits or required policy provisions or that implies that the provisions are

unique to the advertised policy is prohibited.

15.

An advertisement that implies that a common type of policy or a

combination of common benefits is “new”, “unique”, “a bonus”, “a

breakthrough”, or is otherwise unusual is prohibited. The addition of a

novel method of premium payment to an otherwise common plan of

insurance does not render it new or unique.

16.

Language in an advertisement that states or implies that each member

under a family contract is covered as to the maximum benefits advertised,

where that is not the fact, is prohibited.

17.

An advertisement that contains statements such as “anyone can apply”, or

“anyone can join”, other than with respect to a guaranteed-issue policy for

which administrative procedures exist to assure that the policy is issued

within a reasonable period of time after the application is received by the

insurer, is prohibited.

18.

An advertisement that states or implies immediate coverage of a policy is

prohibited unless administrative procedures exist so that the policy is

issued within fifteen (15) business days after the insurer receives the

completed application.

19.

An advertisement that contains statements such as “here is all you do to

apply”, or “simply” or “merely” to refer to the act of applying for a policy

that is not a guaranteed-issue policy is prohibited unless it refers to the

fact that the application is subject to acceptance or approval by the

insurer.

20.

An advertisement of accident and sickness insurance sold by direct

response shall not state or imply that because no insurance producer will

call and no commissions will be paid to producers that it is a low cost plan,

or use other similar words or phrases because the cost of advertising and

servicing the policies is a substantial cost in the marketing by direct

response.

21.

Applications, request forms for additional information and similar related

materials are prohibited if they resemble paper currency, bonds, stock

certificates, etc., or use any name, service mark, slogan, symbol or device

in a manner that implies that the insurer or the policy advertised is

connected with a government agency, such as the Social Security

Administration or the U.S. Department of Health and Human Services.

22.

An advertisement that implies in any manner that the prospective insured

may realize a profit from obtaining hospital, medical or surgical insurance

coverage is prohibited.

23.

An advertisement that uses words such as “extra”, “special” or “added” to

describe a benefit in the policy is prohibited. No advertisement of a benefit

for which payment is conditioned upon confinement in a hospital or similar

facility shall use words or phrases such as “tax-free”, “extra cash”, “extra

income”, “extra pay”, or substantially similar words or phrases because

these words and phrases have the capacity, tendency or effect of

misleading the public into believing that the policy advertised will, in some

way, enable them to make a profit from being hospitalized.

24.

An advertisement of a hospital or other similar facility confinement benefit

shall not advertise that the amount of the benefit is payable on a monthly

or weekly basis when, in fact, the amount of the benefit payable is based

upon a daily pro rata basis relating to the number of days of confinement

unless the statements of the monthly or weekly benefit amounts are in

juxtaposition with equally prominent statements of the benefit payable on

a daily basis. When the policy contains a limit on the number of days of

coverage provided, the limit shall appear in the advertisement.

25.

An advertisement of a policy covering only one disease or a list of

specified diseases shall not imply coverage beyond the terms of the policy.

Synonymous terms shall not be used to refer to any disease so as to imply

broader coverage than is the fact.

26.

An advertisement that is an invitation to contract for a specified disease

policy that provides lesser benefit amounts for a particular subtype of

disease, shall clearly disclose the subtype and its benefits. This provision

shall not apply to institutional advertisements.

27.

An advertisement of a specified disease policy providing expense benefits

shall not use the term “actual” when the policy only pays up to a limited

amount for expenses. Instead, the term “charges” or substantially similar

language should be used that does not create the misleading impression

that there is full coverage for expenses.

28.

An advertisement that describes any benefits that vary by age shall

disclose that fact.

29.

An advertisement that uses a phrase such as “no age limit”, if benefits or

premiums vary by age or if age is an underwriting factor, shall disclose

that fact.

30.

A television, radio, internet, mail or newspaper advertisement or lead-

generating device that is designed to produce leads either by use of a

coupon, a request to write or e-mail or to call the insurer or a subsequent

advertisement prior to contact shall include information disclosing that a

producer may contact the applicant.

31.

Advertisements, applications, requests for additional information and

similar materials are prohibited if they state or imply that the recipient has

been individually selected to be offered insurance or has had his or her

eligibility for the insurance individually determined in advance when the

advertisement is directed to all persons in a group or to all persons whose

names appear on a mailing list.

32.

An advertisement, including invitations to inquire or invitations to contract,

shall not employ devices that are designed to create undue fear or anxiety

in the minds of those to whom they are directed. Examples of prohibited

devices are:

a.

The use of phrases such as “cancer kills somebody every two

minutes” and “total number of accidents” without reference to the

total population from which the statistics are drawn;

b.

The exaggeration of the importance of diseases rarely or seldom

found in the class of persons to whom the policy is offered;

c.

The use of phrases such as “the finest kind of treatment”, implying

that the treatment would be unavailable without insurance;

d.

The reproduction of newspaper articles, magazine articles,

information from the Internet or other similar published material

containing irrelevant facts and figures;

e.

The use of images that unduly emphasize automobile accidents,

disabled persons or persons confined in beds who are in obvious

distress, persons receiving hospital or medical bills or persons

being evicted from their homes due to their medical bills;

f.

The use of phrases such as “financial disaster”, “financial distress”,

“financial shock”, or another phrase implying that financial ruin is

likely without insurance is only permissible in an advertisement for

major medical expense coverage, individual basic medical expense

coverage or disability income coverage, and only if the phrase does

not dominate the advertisement;

g.

The use of phrases or devices that unduly excite fear of

dependence upon relatives or charity; and

h.

The use of phrases or devices that imply that long sicknesses or

hospital stays are common among the elderly.

B.

Exceptions, Reductions and Limitations

1.

An advertisement shall not contain descriptions of policy limitations,

exceptions or reductions, worded in a positive manner to imply that it is a

benefit, such as describing a waiting period as a “benefit builder” or stating

“even preexisting conditions are covered after two years”. Words and

phrases used in an advertisement to describe the policy limitations,

exceptions and reductions shall fairly and accurately describe the negative

features of the limitations, exceptions and reductions of the policy offered.

2.

An advertisement that is an invitation to contract shall disclose those

exceptions, reductions and limitations affecting the basic provisions of the

policy.

3.

When a policy contains a waiting, elimination, probationary or similar time

period between the effective date of the policy and the effective date of

coverage under the policy or a time period between the date a loss occurs

and the date benefits begin to accrue for the loss, an advertisement that is

subject to the requirements of Section 7.B.2. shall prominently disclose

the existence of such periods.

4.

An advertisement shall not use the words “only”, “just”, “merely”,

“minimum”, “necessary” or similar words or phrases to describe the

applicability of any exceptions, reductions, limitations or exclusions such

as: “This policy is subject to the following minimum exceptions and

reductions.”

5.

An advertisement that is an invitation to contract that fails to disclose the

amount of any deductible or the percentage of any coinsurance factor is

prohibited.

6.

An advertisement for loss-of-time coverage that is an invitation to contract

that sets forth a range of amounts of benefit levels is prohibited unless it

also states that eligibility for the benefits is based upon condition of health,

income or other economic conditions, or other underwriting standards of

the insurer if that is the fact.

7.

An advertisement that refers to “hospitalization for injury or sickness”

omitting the word “covered” when the policy excludes certain sicknesses

or injuries, or that refers to “whenever you are hospitalized”, “when you go

to the hospital”, or “while you are confined in the hospital” omitting the

phrase “for covered injury or sickness”, if the policy excludes certain

injuries or sicknesses, is prohibited. Continued reference to “covered

injury or sickness” is not necessary where this fact has been prominently

disclosed in the advertisement and where the description of sicknesses or

injuries not covered is prominently set forth.

8.

An advertisement that fails to disclose that the definition of “hospital” does

not include certain facilities that provide institutional care such as a

nursing home, convalescent home or extended care facility, when the

facilities are excluded under the definition of hospital in the policy, is

prohibited.

9.

The term “confining sickness” shall be explained in an advertisement

containing the term. The explanation might be as follows: “Benefits are

payable for total disability due to confining sickness only so long as the

insured is necessarily confined indoors.” Captions such as “Lifetime

Sickness Benefits” or “Five-Year Sickness Benefits” are incomplete if the

benefits are subject to confinement requirements. When sickness benefits

are subject to confinement requirements, captions such as “Lifetime

House Confining Sickness Benefits” or “Five-Year House Confining

Sickness Benefits” would be permissible.

10.

An advertisement that fails to disclose any waiting or elimination periods

for specific benefits is prohibited.

11.

An advertisement for a policy providing benefits for specified illnesses

only, such as cancer, or for specified accidents only, such as automobile

accidents, or other policies providing benefits that are limited in nature,

shall clearly and conspicuously in prominent type state the limited nature

of the policy. The statement shall be worded in language identical to or

substantially similar to the following: “THIS IS A LIMITED POLICY”, “THIS

POLICY PROVIDES LIMITED BENEFITS”, or “THIS IS A CANCER ONLY

POLICY”.

Some advertisements disclose exceptions, reductions and limitations as

required, but the advertisement is so lengthy as to obscure the disclosure.

Where the length of an advertisement has this effect, special emphasis

must be given by changing the format to show the restrictions in a manner

that does not minimize, render obscure or otherwise make them appear

unimportant.

C.

Preexisting Conditions

1.

An advertisement that is an invitation to contract shall, in negative terms,

disclose the extent to which any loss is not covered if the cause of the loss

is traceable to a condition existing prior to the effective date of the policy.

The use of the term “preexisting condition” without an appropriate

definition or description shall not be used.

Negative features must be accurately set forth. Any limitation on benefits

including preexisting conditions also must be restated under a caption

concerning exclusions or limitations, notwithstanding that the preexisting

condition exclusion has been disclosed elsewhere in the advertisement.

2.

When an accident and sickness insurance policy does not cover losses

resulting from preexisting conditions, an advertisement of the policy shall

not state or imply that the applicant’s physical condition or medical history

will not affect the issuance of the policy or payment of a claim under the

policy. This regulation prohibits the use of the phrase “no medical

examination required” and phrases of similar import, but does not prohibit

explaining “guaranteed-issue”. If an insurer requires a medical

examination for a specified policy, the advertisement, if it is an invitation to

contract, shall disclose that a medical examination is required.

3.

When an advertisement contains an application form to be completed by

the applicant and returned by mail, the application form shall contain a

question or statement that reflects the preexisting condition provisions of

the policy immediately preceding the blank space for the applicant’s

signature. For example, the application form shall contain a question or

statement substantially as follows:

“Do you understand that this policy will not pay benefits during the first

[insert number] [years, months] after the issue date for a disease or

physical condition that you now have or have had in the past?

“YES”

Or substantially the following statement:

“I understand that the policy applied for will not pay benefits for any loss

incurred during the first [insert number] [years, months] after the issue

date on account of disease or physical condition that I now have or have

had in the past.”

Section 8

Necessity for Disclosing Policy Provisions Relating to Renewability,

Cancellability and Termination

A.

An advertisement that is an invitation to contract shall disclose the provisions

relating to renewability, cancellability and termination, and any modification of

benefits, losses covered, or premiums because of age or for other reasons, in a

manner that shall not minimize or render obscure the qualifying conditions.

B.

Advertisements of cancellable accident and sickness insurance policies shall

state that the insurer may cancel or renew the contract using language

substantially similar to the following: “This policy is renewable at the option of the

company.”, or “The company has the right to refuse renewal of this policy.”, or

“Renewable at the option of the insurer.”, or “This policy can be cancelled by the

company at any time.”

C.

Advertisements of insurance policies that are guaranteed renewable, cancellable

or renewable at the option of the insurer shall disclose that the insurer has the

right to increase premium rates if the policy so provides.

D.

Qualifying conditions that constitute limitations on the permanent nature of the

coverage shall be disclosed in advertisements of insurance policies that are

guaranteed renewable, cancellable or renewable at the option of the insurer.

Examples of qualifying conditions include, but are not limited to age limits;

reservation of a right to increase premiums; and the establishment of aggregate

limits.

1.

Provisions for reduction of benefits at stated ages shall be set forth. For

example, a policy may contain a provision that reduces benefits fifty

percent (50%) after age sixty (60) although it is renewable to age sixty-five

(65). Such a reduction shall be set forth. Also, a provision for the

elimination of certain hazards at any specific ages or after the policy has

been in force for a specified time shall be set forth.

2.

An advertisement for a policy that provides for step-rated premium rates

based upon the policy year or the insured’s attained age shall disclose the

rate increases and the times or ages at which the premiums increase.

Section 9

Standards for Marketing

A.

An insurer, directly or through its producers, shall:

1.

Establish marketing procedures to assure that any comparison of policies

by its producers will be fair and accurate;

2.

Establish marketing procedures assuring excessive insurance is not sold

or issued, except this requirement does not apply to group health benefit

plans and disability income coverage; and

3.

Establish auditable procedures for verifying compliance with Section 9.

B.

The following acts and practices are prohibited:

1.

Twisting. Knowingly making any misleading representation or incomplete

or fraudulent comparison of insurance policies or insurers for the purpose

of inducing, or tending to induce, a person to lapse, forfeit, surrender,

terminate, retain, pledge, assign, borrow on, or convert an insurance

policy, or to take out a policy of insurance with another insurer;

2.

High Pressure Tactics. Employing a method of marketing that has the

effect of inducing the purchase of insurance, or tends to induce the

purchase of insurance through force, fright, threat, whether explicit or

implied, or undue pressure to purchase or recommend the purchase of

insurance; and

3.

Cold Lead Advertising. Making use directly or indirectly of any method of

marketing that fails to disclose in a conspicuous manner that a purpose of

the method of marketing is solicitation of insurance and that contact will be

made by an insurance producer or insurer.

4.

The marketing of any health coverage plan which is not ACA-compliant as

an alternative to, or a substitute for, a health benefit plan which meets

federal and state requirements under the ACA.

C.

Summary of Benefits and Coverage (SBC)

1.

The SBC form and the Colorado Supplement to the Summary of Benefits

and Coverage form must be in compliance with the requirements of state

and federal law, and Colorado Insurance Regulation 4-2-20.

2.

The SBC must contain, in plain language, simple and consistent

information about the benefits and coverage of the stated health benefit

plan as specified in 45 C.F.R. § 147.200(a).

2.

If upon review the Division finds that an SBC or the Colorado Supplement

to the Summary of Benefits form is misleading, deceptive, or

misrepresentative of the benefits in the stated health benefit plan, the

submitting insurer may be found to have violated the marketing standards

found at § 10-3-1104, C.R.S.

Section 10 Testimonials or Endorsements by Third Parties

A.

Testimonials and/or endorsements used in advertisements shall be genuine,

represent the current opinion of the author, be applicable to the policy advertised

and be accurately reproduced. The insurer, in using a testimonial or

endorsement, makes as its own all of the statements contained in it, and the

advertisement, including the statement, is subject to all of the provisions of this

regulation. When a testimonial or endorsement is used more than one (1) year

after it was originally given, a confirmation must be obtained.

B.

A person shall be deemed a “spokesperson” if the person making the testimonial

or endorsement:

1.

Has a financial interest in the insurer or a related entity as a stockholder,

director, officer, employee or otherwise;

2.

Has been formed by the insurer, is owned or controlled by the insurer, its

employees, or the person or persons who own or control the insurer;

3.

Has any person in a policy-making position who is affiliated with the

insurer in any of the above described capacities; or

4.

Is in any way directly or indirectly compensated for making a testimonial or

endorsement.

C.

Any person or agency acting as a spokesperson, as defined in Section 10.B.,

who performs any of the following acts in an advertisement shall be considered

soliciting an insurance product, and such person or agency shall be a licensed

insurance producer or agency pursuant to Colorado insurance law:

1.

Individual who solicits, negotiates, effects, procures, delivers, renews,

continues or binds; or

2.

A corporation, partnership, association, or other legal entity transacting the

business of insurance.

D.

The fact of a financial interest or the proprietary or representative capacity of a

spokesperson shall be disclosed in an advertisement and shall be accomplished

in the introductory portion of the testimonial or endorsement in the same form

and with equal prominence. If a spokesperson is directly or indirectly

compensated for making a testimonial or endorsement, the fact shall be

disclosed in the advertisement. The requirement of this disclosure may be fulfilled

by use of the phrase “Paid Endorsement” or words of similar import in a type

style and size at least equal to that used for the spokesperson’s name or the

body of the testimonial or endorsement, whichever is larger. In the case of

television or radio advertising, the required disclosure shall be accomplished in

the introductory portion of the advertisement and shall be given prominence.

E.

The disclosure requirements of this regulation shall not apply where the sole

financial interest or compensation of a spokesperson, for all testimonials or

endorsements made on behalf of the insurer, consists of the payment of union

scale wages required by union rules, and if the payment is actually the scale for

TV or radio performances.

F.

An advertisement shall not state or imply that an insurer or an accident and

sickness insurance policy has been approved or endorsed by any individual,

group of individuals, society, association or other organizations, unless that is the

fact, and unless any proprietary relationship between an organization and the

insurer is disclosed. If the entity making the endorsement or testimonial has been

formed by the insurer or is owned or controlled by the insurer or the person or

persons who own or control the insurer, the fact shall be disclosed in the

advertisement. If the insurer or an officer of the insurer formed or controls the

association, or holds any policy-making position in the association, that fact must

be disclosed.

G.

When a testimonial refers to benefits received under an accident and sickness

insurance policy, the specific claim data, including claim number, date of loss and

other pertinent information shall be retained by the insurer for inspection for a

period of four (4) years or until the filing of the next regular report of examination

of the insurer, whichever is the longer period of time. The use of testimonials that

do not correctly reflect the present practices of the insurer or that are not

applicable to the policy or benefit being advertised is not permissible.

Section 11 Use of Statistics

A.

An advertisement relating to the dollar amounts of claims paid, the number of

persons insured, or similar statistical information relating to an insurer or policy

shall not use irrelevant facts, and shall not be used unless it accurately reflects

all of the current and relevant facts. The advertisement shall not imply that the

statistics are derived from the policy advertised unless that is the fact, and when

applicable to other policies or plans, shall specifically so state.

1.

An advertisement shall specifically identify the accident and sickness

insurance policy to which statistics relate and where statistics are given

that are applicable to a different policy, it shall be stated clearly that the

data does not relate to the policy being advertised.

2.

An advertisement using statistics that describe an insurer, such as assets,

corporate structure, financial standing, age, product lines or relative

position in the insurance business, may be irrelevant and, if used at all,

shall be used with extreme caution because of the potential for misleading

the public. As a specific example, an advertisement for accident and

sickness insurance that refers to the amount of life insurance which the

insurer has in force or the amounts paid out in life insurance benefits is not

permissible unless the advertisement clearly indicates the amount paid out

for each line of insurance.

B.

An advertisement shall not represent or imply that claim settlements by the

insurer are “liberal” or “generous”, or use words of similar import, or that claim

settlements are or will be beyond the actual terms of the contract. An unusual

amount paid for a unique claim for the policy advertised is misleading and shall

not be used.

C.

The source of any statistics used in an advertisement shall be identified in the

advertisement.

Section 12 Identification of Plan or Number of Policies

A.

An advertisement that uses the word “plan” without prominently identifying it as

an accident and sickness insurance policy is prohibited.

B.

When a choice of the amount of benefits is referred to, an advertisement that is

an invitation to contract shall disclose that the amount of benefits provided

depends upon the plan selected and that the premium will vary with the amount

of the benefits selected.

C.

When an advertisement that is an invitation to contract refers to various benefits

that may be contained in two (2) or more policies, other than group master

policies, the advertisement shall disclose that the benefits are provided only

through a combination of policies.

Section 13 Disparaging Comparisons and Statements

An advertisement shall not directly or indirectly make unfair or incomplete comparisons

of policies or benefits or comparisons of non-comparable policies of other insurers, and

shall not disparage competitors, their policies, services or business methods, and shall

not disparage or unfairly minimize competing methods of marketing insurance.

A.

An advertisement shall not contain statements such as “no red tape” or “here is

all you do to receive benefits”.

B.

Advertisements that state or imply that competing insurance coverages

customarily contain certain exceptions, reductions or limitations not contained in

the advertised policies are prohibited unless the exceptions, reductions or

limitations are contained in a substantial majority of the competing coverages.

C.

Advertisements that state or imply that an insurer’s premiums are lower or that its

loss ratios are higher because its organizational structure differs from that of

competing insurers are prohibited.

Section 14 Jurisdictional Licensing and Status of Insurer

A.

An advertisement that is intended to be seen or heard beyond the limits of the

jurisdiction in which the insurer is licensed shall not imply licensing beyond those

limits.

B.

An advertisement shall not create the impression directly or indirectly that the

insurer, its financial condition or status, or the payment of its claims, or the

merits, desirability, or advisability of its policy forms or kinds of plans of insurance

are approved, endorsed or accredited by any division or agency of the state or

the federal government. Terms such as “official” or words of similar import, used

to describe any policy or application form are prohibited because of the potential

for deceiving or misleading the public.

C.

An advertisement shall not imply that approval, endorsement or accreditation of

policy forms or advertising has been granted by any division or agency of the

state or federal government. Approval of either policy forms or advertising shall

not be used by an insurer to imply or state that a governmental agency has

endorsed or recommended the insurer, its policies, advertising or its financial

condition.

D.

For purposes of Section 14 and the multistate plan provisions of the ACA, a

contract between the Office of Personal Management and a multistate insurer

does not constitute approval, endorsement or accreditation by the federal

government.

Section 15 Identity of Insurer

A.

The name of the actual insurer shall be stated in all of its advertisements. The

form number or numbers of the policy advertised shall be stated in an

advertisement that is an invitation to contract. An advertisement shall not use a

trade name, an insurance group designation, name of the parent company of the

insurer, name of a particular division of the insurer, service mark, slogan, symbol

or other device that without disclosing the name of the actual insurer, would have

the capacity and tendency to mislead or deceive as to the true identity of the

insurer.

B.

An advertisement shall not use any combination of words, symbols, or physical

materials that by their content, phraseology, shape, color or other characteristics

are so similar to combination of words, symbols or physical materials used by

agencies of the federal government or of this state, or otherwise appear to be of

such a nature that it tends to confuse or mislead prospective insureds into

believing that the solicitation is in some manner connected with an agency of the

municipal, state or federal government.

C.

Advertisements, envelopes or stationery that employ words, letters, initials,

symbols or other devices that are similar to those used in governmental agencies

or by other insurers are not permitted if they may lead the public to believe:

1.

That the advertised coverages are somehow provided by or are endorsed

by the governmental agencies or the other insurers; or

2.

That the advertiser is the same as is connected with or is endorsed by the

governmental agencies or the other insurers.

D.

An advertisement shall not use the name of a state or political subdivision of a

state in a policy name or description.

E.

An advertisement in the form of envelopes or stationery of any kind may not use

any name, service mark, slogan, symbol or any device in a manner that implies

that the insurer or the policy advertised, or that any producer who may call upon

the consumer in response to the advertisement, is connected with a

governmental agency, such as the Social Security Administration.

F.

An advertisement may not incorporate the word “Medicare” in the title of the plan

or policy being advertised unless, wherever it appears, the word is qualified by

language differentiating it from Medicare. The advertisement, however, shall not

use the phrase “[ ] Medicare Department of the [ ] Insurance Company”, or

language of similar import.

G.

An advertisement may not imply that the reader may lose a right or privilege or

benefit under federal, state or local law if he or she fails to respond to the

advertisement.

H.

The use of letters, initials or symbols of the corporate name or trademark that

would have the tendency or capacity to mislead or deceive the public as to the

true identity of the insurer is prohibited unless the true, correct and complete

name of the insurer is in close conjunction and in the same size type as the

letters, initials or symbols of the corporate name or trademark.

I.

The use of the name of an agency or “[ ] Underwriters” or “[ ] Plan” in type, size

and location so as to have the capacity and tendency to mislead or deceive as to

the true identity of the insurer is prohibited.

J.

The use of an address so as to mislead or deceive as to true identity of the

insurer, its location or licensing status is prohibited.

K.

An insurer shall not use, in the trade name of its insurance policy, any

terminology or words so similar to the name of a governmental agency or

governmental program as to have the tendency to confuse, deceive or mislead

the prospective purchaser.

L.

Advertisements used by producers of an insurer shall have prior written approval

of the insurer before they may be used.

M.

A producer who makes contact with a consumer, as a result of acquiring that

consumer’s name from a lead-generating device, shall disclose that fact in the

initial contact with the consumer. A producer or insurer may not use names

produced from lead-generating devices that do not comply with the requirements

of this regulation.

Section 16 Group or Quasi-Group Implications

A.

An advertisement of a particular policy shall not state or imply that prospective

insureds become group or quasi-group members covered under a group policy

and as members, enjoy special rates or underwriting privileges, unless that is the

fact.

B.

This regulation prohibits the solicitations of a particular class, such as

governmental employees, by use of advertisements which state or imply that

their occupational status entitles them to reduced rates on a group or other basis

when, in fact, the policy being advertised is sold only on an individual basis at

regular rates.

C.

Advertisements that indicate that a particular coverage or policy is exclusively for

“preferred risks” or a particular segment of the population or that a particular

segment of the population is an acceptable risk, when the distinctions are not

maintained in the issuance of policies, are prohibited.

D.

An advertisement to join an association, trust or discretionary group that is also

an invitation to contract for insurance coverage shall clearly disclose that the

applicant will be purchasing both membership in the association, trust or

discretionary group and insurance coverage. The insurer shall solicit insurance

coverage on a separate and distinct application that requires a separate

signature. The separate and distinct applications required need not be on

separate documents or contained in a separate mailing. The insurance program

shall be presented so as not to conceal the fact that the prospective members

are purchasing insurance as well as applying for membership, if that is the case.

Similarly, it is prohibited to use terms such as “enroll” or “join” to imply group or

blanket insurance coverage when that is not the fact.

E.

Advertisements for group or franchise group plans that provide a common benefit

or a common combination of benefits shall not imply that the insurance coverage

is tailored or designed specifically for that group, unless that is the fact.

Section 17 Introductory, Initial or Special Offers

A.

An advertisement of an individual policy shall not directly or by implication

represent that a contract or combination of contracts is an introductory, initial or

special offer, or that applicants will receive substantial advantages not available

at a later date, or that the offer is available only to a specified group of

individuals, unless that is the fact. An advertisement shall not contain phrases

describing an enrollment period as “special”, “limited”, or similar words or

phrases when the insurer uses the enrollment periods as the usual method of

marketing accident and sickness insurance.

B.

This regulation prohibits any statement or implication to the effect that only a

specific number of policies will be sold, or that a time is fixed for the

discontinuance of the sale of the particular policy advertised because of special

advantages available in the policy, unless that is the fact.

C.

An advertisement shall not offer a policy that utilizes a reduced initial premium

rate in a manner that overemphasizes the availability and the amount of the initial

reduced premium. When an insurer charges an initial premium that differs in

amount from the amount of the renewal premium payable on the same mode, the

advertisement shall not display the amount of the reduced initial premium either

more frequently or more prominently than the renewal premium, and both the

initial reduced premium and the renewal premium must be stated in juxtaposition

in each portion of the advertisement where the initial reduced premium appears.

D.

Special awards, such as a “safe drivers’ award”, shall not be used in connection

with advertisements of accident and sickness insurance.

Section 18 Statements about an Insurer

An advertisement shall not contain statements that are untrue in fact, or by implication

misleading, with respect to the assets, corporate structure, financial standing, age or

relative position of the insurer in the insurance business. An advertisement shall not

contain a recommendation by any commercial rating system unless it clearly indicates

the purpose of the recommendation and the limitations of the scope and extent of the

recommendations.

Section 19 Enforcement Procedures

Each insurer shall maintain at its home or principal office a complete file containing

every printed, published or prepared advertisement of its individual policies and typical

printed, published or prepared advertisements of its blanket, franchise and group

policies hereafter disseminated in this or any other state, whether or not licensed in

another state, with a notation attached to each advertisement that indicates the manner

and extent of distribution and the form number of any policy advertised. The file shall be

subject to regular and periodical inspection by the Commissioner. All of these

advertisements shall be maintained in a file for a period of either four (4) years or until

the filing of the next regular report on examination of the insurer, whichever is the longer

period of time.

Section 20 Severability

If any provisions of this regulation or the application of it to any person or circumstances

is for any reason held to be invalid, the remainder of the regulation shall not be affected.

Section 21 Incorporated Materials

45 C.F.R. § 147.200(a) shall mean 45 C.F.R. § 147.200(a) as published on the effective

date of this regulation and does not include later amendments to or editions of 45 C.F.R.

§ 147.200(a). A copy of 45 C.F.R. § 147.200(a) may be examined during regular

business hours at the Colorado Division of Insurance, 1560 Broadway, Suite 850,

Denver, Colorado 80202. A certified copy of 45 C.F.R. § 147.200(a) may be requested

from the Colorado Division of Insurance, 1560 Broadway, Suite 850, Denver, Colorado

80202. A charge for certification or copies may apply. A copy may also be obtained

online at www.ecfr.gov.

Section 22 Enforcement

Noncompliance with this regulation may result in the imposition of any of the sanctions

made available in the Colorado statutes pertaining to the business of insurance, or other

laws, which include the imposition of civil penalties, issuance of cease and desist

orders, and/or suspensions or revocation of license, subject to the requirements of due

process.

Section 23 Effective Date

This regulation is effective May 15, 2026.

Section 24 History

Originally issued as Regulation 75-2, effective December 22, 1975.

Renumbered as Regulation 4-2-3, effective June 1, 1992.

Amended regulation, effective July 1, 1993.

Repealed and Repromulgated in full, effective February 1, 2001.

Amended regulation, effective August 1, 2001.

Amended regulation, effective February 1, 2003.

Amended regulation, effective May 1, 2010.

Amended regulation, effective October 1, 2013.

Amended regulation, effective April 15, 2014.

Amended regulation, effective February 1, 2020.

Amended regulation, effective May 15, 2026.

Regulation 4-2-5

[Repealed eff. 05/01/2010]

Regulation 4-2-6

CONCERNING THE DEFINITION OF THE TERM

“COMPLICATIONS OF PREGNANCY”

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Rules

Section 6

Severability

Section 7

Enforcement

Section 8

Effective Date

Section 9

History

Section 1

Authority

This amended regulation is promulgated and adopted by the Commissioner of

Insurance under the authority of §§ 10-1-109, 10-3-1110 and 10-16-109 and, C.R.S.

Section 2

Scope and Purpose

The purpose of this regulation is to standardize the definition of the term “complications

of pregnancy” as used in sickness and accident insurance policies covering residents of

this state consistent with the commonly perceived connotation of this term by the

general public.

Section 3

Applicability

This regulation shall apply to all companies and entities marketing or selling sickness

and accident policies providing coverage for disability due to sickness issued by an

entity subject to the provisions of Part 2 of Article 16 of Title 10, and to those companies

and entities marketing or selling individual or group services or indemnity contracts

subject to the provisions of Part 3 of Article 16 of Title 10.

Section 4

Definitions

For the purposes of this regulation “complications of pregnancy” shall mean:

A.

Conditions (when the pregnancy is not terminated) whose diagnoses are distinct

from pregnancy but are adversely affected by pregnancy or are caused by

pregnancy, such as acute nephritis, nephrosis, cardiac decompensation, missed

abortion, and similar medical and surgical conditions of comparable severity, but

shall not include false labor, occasional spotting, physician-prescribed rest during

the period of pregnancy, morning sickness, hyperemesis gravidarum,

preeclampsia, and similar conditions associated with the management of a

difficult pregnancy not constituting a nosologically distinct complication of

pregnancy;

B.

Non-elective cesarean section, ectopic pregnancy, which is terminated, and

spontaneous termination of pregnancy, which occurs during a period of gestation

in which a viable birth is not possible.

Section 5

Rules

All companies marketing sickness and accident insurance policies, as defined in this

regulation, delivered or issued for delivery in the State of Colorado shall use in each

insurance policy or certificate of insurance a definition of the complications of pregnancy

no more restrictive than that required by this regulation, and must be in compliance with

the requirements found at § 10-16-104(2), C.R.S.

Section 6

Severability

If any provisions of this regulation or the application thereof to any person or

circumstance is for any reason held to be invalid, the remainder of the regulation shall

not be affected.

Section 7

Enforcement

Noncompliance with this regulation may result in the imposition of any of the sanctions

made available in the Colorado statutes pertaining to the business of insurance, or other

laws, which include the imposition of civil penalties, issuance of cease and desist

orders, and/or suspensions or revocation of license, subject to the requirements of due

process.

Section 8

Effective Date

This amended regulation shall become effective February 1, 2016.

Section 9

History

Originally issued as Regulation 78-16, effective June 30, 1979.

Amended Regulation 78-16, effective October 1, 1983.

Renumbered as Regulation 4-2-6, effective June 1, 1992.

Amended effective November 1, 2000.

Regulation amended, effective March 2, 2010.

Regulation amended effective February 1, 2016.

Regulation 4-2-8

CONCERNING REQUIRED HEALTH INSURANCE BENEFITS

FOR HOME HEALTH SERVICES AND HOSPICE CARE

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Requirements for Home Health Services

Section 6

Requirements for Hospice Care

Section 7

Additional Requirements for Home Health Services

Section 8

Severability

Section 9

Enforcement

Section 10

Effective Date

Section 11

History

Section 1

Authority

This regulation is promulgated and adopted by the Commissioner of Insurance under

the authority of § § 10-1-109 and 10-16-104(8)(d), C.R.S.

Section 2

Scope and Purpose

The purpose of this regulation is to establish requirements for standard policy

provisions, which state clearly and completely the criteria for and extent of coverage for

home health services and hospice care and to facilitate prompt and informed decisions

regarding patient placement and discharge.

Section 3

Applicability

The requirements of this regulation shall apply to:

A.

Insurers subject to the provisions of Part 2 of Article 16 of Title 10, C.R.S. and

non-profit hospital, medical surgical, and health service corporations subject to

the provisions of Part 3 of Article 16 of Title 10, C.R.S., which provide: hospital,

surgical or major medical coverage on an expense incurred basis, except as

noted in paragraph B below, issued on or after the effective date hereof and to all

such policies renewed after said date, unless the insurer certifies in writing to the

Commissioner of Insurance that it no longer issues the type of policy being

renewed. “Renewed” or “renewal” means to continue coverage for an additional

policy period upon expiration of the current policy period of a policy.

B.

This regulation does not apply to the following:

1.

Medicare supplement policies issued under § 10-18-101 et seq., C.R.S.;

2.

Credit accident and health policies issued under § 10-10-101 et seq.,

C.R.S.;

3.

This regulation does not apply to health benefit plans as defined at § 10-

16-102(32), C.R.S.; and

4.

Any insurance policy, contract, or certificate which provides coverage

exclusively for:

a.

Disability loss of income;

b.

Dental services;

c.

Optical services;

d.

Hospital confinement indemnity;

e.

Accident only; or

f.

Prescription drug services.

Section 4

Definitions

A.

“Benefit period” means, for purposes of this regulation, a hospice care service

period of ninety (90) days, during which services are provided on a regular basis.

B.

“Bereavement” means, for purposes of this regulation, that period of time during

which survivors mourn a death and experience grief. Bereavement services

mean support services to be offered during the bereavement period.

C.

“Core services” means, for purposes of this regulation, nursing services, pastoral

services, trained volunteers, and psychosocial services routinely provided by

hospice staff or volunteers.

D.

“Evaluation” means, for purposes of this regulation, an objective, formal and

regular assessment of the functioning of the organization and of the provision of

hospice care.

E.

“Home care services” means, for purposes of this regulation, hospice services,

which are provided in the place the patient designates as his/her primary

residence, which may be a private residence, retirement community, assisted

living, nursing or Alzheimer facility.

F.

“Home health agency” means, for purposes of this regulation, an agency which

has been certified by the Colorado Department of Public Health and Environment

as meeting the provisions of Title XVIII of the Federal “Social Security Act”, as

amended, for licensed or certified home health agencies and which is engaged in

arranging and providing nursing services, home health aide services and other

therapeutic and related services.

G.

“Home health services” means, for purposes of this regulation, the following

services provided by a certified home health agency under a plan of care to

eligible persons in their place of residence:

1.

Skilled nursing services;

2.

Certified and licensed nurse aide services, as defined in § 12-38.1-102(3),

C.R.S.;

3.

Physical therapy, occupational therapy, or speech and language pathology

services, as such therapy and services are defined in § 12-43.7-101, et

seq, C.R.S.;

4.

Social Work Practice services, as defined in § 12-43-403,C.R.S., by a

licensed social worker. “Licensed Social Worker” shall have the same

meaning as provided in § 12-43-201(5.5), C.R.S.; and

5.

Medical supplies, equipment and appliances suitable for use in the home.

H.

“Home health visit” means, for purposes of this regulation, each visit by a

member of the home health team, provided on a part-time and intermittent basis

as included in the plan of care. Services of up to four (4) hours by a home health

aide shall be considered as one visit.

I.

“Homemaker services” means, for purposes of this regulation, services provided

to the patient, which include:

1.

General household activities including the preparation of meals and

routine household care; and

2.

Teaching, demonstrating and providing patient/family with household

management techniques that promote self-care, independent living and

good nutrition.

J.

“Hospice” means, for purposes of this regulation, a facility or service licensed by

the Department of Public Health and Environment under a centrally administered

program of palliative, supportive, and interdisciplinary team services providing

physical, psychosocial, spiritual, and bereavement care for terminally ill

individuals and their families to be available 24 hours, 7 days a week. Hospice

services shall be provided in the home, a hospice facility, and/or other licensed

health facility. Hospice services include but shall not necessarily be limited to the

following: nursing, physician, certified nurse aide, nursing services delegated to

other assistants, homemaker, physical therapy, pastoral counseling, trained

volunteer, and social services.

K.

“Hospice care” means, for purposes of this regulation, an alternative way of

caring for terminally ill individuals which stresses palliative care as opposed to

curative or restorative care. Hospice care focuses upon the patient/family as the

unit of care. Supportive services are offered to the family before and after the

death of the patient. Hospice care is not limited to medical intervention, but

addresses physical, psychosocial, and spiritual needs of the patient. Hospice

care is planned, implemented and evaluated by an interdisciplinary team of

professionals and volunteers.

L.

Hospice levels of care:

1.

“Routine home care” means, for purposes of this regulation, the level of

care a patient/family receives according to the interdisciplinary team's plan

of care each day the patient is at home and not receiving continuous

home care.

2.

“Continuous home care” means, for purposes of this regulation, the level

of care received by the patient during a period of medical crisis to achieve

palliation and management of acute medical symptoms. The

preponderance of care must be nursing care (at least half) and care must

be provided for a period of at least eight hours (need not be consecutive)

in one calendar day. Home health aide and homemaker services, or both,

may be provided to supplement nursing care.

3.

“Inpatient hospice respite care” means, for purposes of this regulation, the

level of care received when the patient is in a licensed facility to provide

the caregiver a period of relief. Inpatient respite care may be provided only

on an intermittent, non-routine, short-term basis. It may be limited to

periods of five days or less.

4.

“General inpatient hospice care” means, for purposes of this regulation,

the level of care the patient receives when short-term inpatient care for

pain control or acute symptom management cannot be achieved in the

home. This level of care must be provided in a licensed facility with the

approval of the physician and the hospice.

M.

“Hospice per diem rate” means, for purposes of this regulation, the

predetermined rate for each day in which an individual is enrolled in a hospice

program and under its care, without regard to which, if any, services are actually

provided on a specific day.

N.

“Inpatient hospice facility” means, for purposes of this regulation, a facility which

shall directly provide inpatient services and may provide any or all of the

continuum of hospice services as described in Section 4.E. These services are

provided twenty-four (24) hours a day and, to the extent possible, in a homelike

setting.

O.

“Inpatient services” means, for purposes of this regulation, hospice services

provided to patient/families who require twenty-four (24) hour nursing supervision

in a licensed hospice facility or other licensed health facility. In the event that a

hospice provides inpatient services in a licensed health facility other than a

hospice, such hospice shall maintain administrative control of and responsibility

for the provision of all hospice services.

P.

“Interdisciplinary team” means, for purposes of this regulation, a group of

qualified individuals, which shall include, but is not limited to, a physician,

registered nurse, clergy/counselors, social workers, volunteer director, and/or

trained volunteers, and appropriate staff who collectively have expertise in

meeting the special needs of hospice patient/families.

Q.

“Palliative services” means, for purposes of this regulation, those services and/or

interventions which are not curative but which produce the greatest degree of

relief from pain and other symptoms of the terminal illness.

R.

“Patient” means, for purposes of this regulation, an individual in the terminal

stage of illness who has an anticipated life expectancy of six (6) months or less

and who alone or in conjunction with a family member or members, has

voluntarily agreed to admission and been accepted into a hospice.

S.

“Patient/family” means, for purposes of this regulation, one unit of care consisting

of those individuals who are closely linked with the patient, including the

immediate family, the primary or designated care giver and individuals with

significant personal ties.

T.

“Personal care” means services provided to a patient in his or her home to meet

the patient's physical requirements and/or to accommodate a patient's

maintenance or supportive needs.

U.

“Unrelated illness” means, for purposes of this regulation, a diagnosed condition,

which is not a direct result of the terminal diagnosis or its treatment and the

expected course of that terminal illness.

Section 5

Requirements for Home Health Services

A.

General Policy Provisions Pertaining to Home Health Care.

1.

The policy offering shall provide that home health services are to be

covered when such services are necessary as alternatives to

hospitalization or in place of hospitalization. Prior hospitalization shall not

be required.

2.

The policy offering shall require, as a condition of coverage that home

health care services are to be rendered pursuant to a physician's written

order, under a plan of care established by the physician in collaboration

with a home health care provider.

3.

The policy offering may use case management requirements including, but

not limited to, authorization of benefits prior to the beginning of services

and review of treatment at periodic intervals.

4.

The policy may require that all home health services included in the plan

of care be coordinated by the home health agency.

B.

Benefits for Home Health Care Services.

1.

Benefit levels for home health care services shall not be less than the

deductible, coinsurance and stop loss provisions of the overall policy or

certificate.

2.

The policy or certificate may contain a limitation on the number of home

health visits, but no policy offered may provide for fewer than sixty (60)

home health visits in any calendar year.

3.

The policy offered shall include benefits for the following services:

a.

Skilled nursing services provided by a Registered or Licensed

Nurse;

b.

Certified nurse aide services;

c.

Physical therapy;

d.

Occupational therapy;

e.

Speech and language pathology;

f.

Respiratory and inhalation therapy;

g.

Nutrition counseling by a nutritionist or dietitian;

h.

Social work practice services;

i.

Medical supplies;

j.

Prosthesis and orthopedic appliances; and

k.

Rental or purchase of durable medical equipment.

4.

The services identified in subsections B.3.i. through B.3.l. of this section

may be included elsewhere in the policy, rather than specifically in the

home health benefit provisions.

C.

Limitations and Exclusions.

1.

Benefits for home health services may be governed by policy or certificate

limitations and exclusions, including but not limited to, exclusion for non-

skilled personal care and conditions for surgery excluded in the policy or

certificate.

2.

The following items need not be considered as eligible expenses under

home health care benefits:

a.

Services or supplies for personal comfort or convenience, including

homemaker services;

b.

Services related to well-baby care; and

c.

Food services or meals other than dietary counseling excluding

tube feedings.

Section 6

Requirements for Hospice Care

A.

General Provisions Pertaining to Hospice Care.

1.

The policy offering shall provide that hospice care services are to be

covered when such services are provided under active management

through a hospice which is responsible for coordinating all hospice care

services, regardless of the location or facility in which such services are

furnished.

2.

The policy offering shall provide that benefits are allowed only for

individuals who are terminally ill and have a life expectancy of six (6)

months or less, except that benefits may exceed six (6) months should the

patient continue to live beyond the prognosis for life expectancy, in which

case the benefits shall continue at the same rate for one additional benefit

period. After the exhaustion of three benefit periods, the insurer's case

management staff shall work with the individual's attending physician and

the hospice's Medical Director to determine the appropriateness of

continuing hospice care.

3.

The policy offering shall require a physician's certification of the patient's

illness, including a prognosis for life expectancy and the appropriateness

for hospice care. The insurer may also require a copy of the patient’s plan

of care and any changes made to the level of care or to the plan of care.

4.

The policy offering may use case management requirements including, but

not limited to, authorization of benefits prior to the beginning of services

and review of care at periodic intervals.

5.

The policy offering shall clearly indicate that services and charges incurred

in connection with an unrelated illness will be processed in accordance

with policy coverage provisions applicable to all other illnesses and/or

injuries.

B.

Benefits for Hospice Care Services.

1.

Benefits for hospice care services shall be governed by the deductible,

coinsurance and stop-loss provisions of the overall policy or certificate.

The details of these provisions will be forwarded and updated to the

provider upon authorization of benefits.

2.

The policy or certificate may contain a dollar limitation on routine home

care hospice benefits. Other services provided by or through the hospice

that are available to the insured will be negotiated at a hospice per diem

rate with the hospice provider. Any policy offered shall provide a benefit of

no less than $150 per day for any combination of the following routine

home care services, which are planned, implemented and evaluated by

the interdisciplinary team:

a.

Intermittent and twenty-four (24) hour on-call professional nursing

services provided by or under the supervision of a Registered

Nurse;

b.

Intermittent and twenty-four (24) hour on-call social/counseling

services: and;

c.

Certified nurse aide services or nursing services delegated to other

persons pursuant to § 12-38-132, C.R.S.

The total benefit for each benefit period for these services shall not

be less than the per diem benefit multiplied by ninety (90) days.

3.

The policy offering shall include the following benefits, subject to the

policy's deductible, coinsurance and stoploss provisions, which are

exclusive of and shall not be included in the dollar limitation for hospice

care benefits as specified in (2) above:

a.

Bereavement support services for the family of the deceased

person during the twelve month period following death, and in no

event shall this maximum benefit be less than $1400.

b.

Short-term general inpatient (acute) hospice care or continuous

home care which may be required during a period of crisis, for pain

control or symptom management and shall be paid consistent with

any other sickness or illness (i.e., not included in the per diem

limitation specified in subsection 2 of this section). Such care shall

require prior authorization of the interdisciplinary team and may,

except for emergencies, weekends or holidays, require prior

authorization by the insurer, provided, however, that the insurer

may not require prior authorization when the transfer to the higher

level of care was necessary during the insurer’s non-business

hours if the hospice seeks the authorization during the insurer’s first

business day;

c.

Medical supplies;

d.

Drugs and biologicals;

e.

Prosthesis and orthopedic appliances;

f.

Oxygen and respiratory supplies;

g.

Diagnostic testing;

h.

Rental or purchase of durable equipment;

i.

Transportation;

j.

Physicians services;

k.

Therapies including physical, occupational and speech; and

l.

Nutritional counseling by a nutritionist or dietitian.

C.

Limitations and Exclusions.

Benefits for hospice care services shall be governed by policy or certificate limitations

and exclusions, to the extent that such policy or certificate is not in conflict with the

statutory mandate that hospice care be offered with the minimum benefits required by

this regulation. The insurer must notify the hospice in writing of any such limitation of

benefits, and must do so within two business days of a request to determine if specific

services are excluded or authorized under the coverage.

Section 7

Additional Requirements for Home Health Care Services and Hospice

Care

A.

The offer to a policyholder to purchase home health care and hospice care

coverage must be in writing, either by means of a prominent statement or

question on the application for the policy or on a separate form.

B.

Nothing in this regulation shall prohibit the insurer from offering a higher level of

benefits than required herein.

Section 8

Severability

If any provision of this regulation or the application of it to any person or circumstance is

for any reason held to be invalid, the remainder of the regulation shall not be affected.

Section 9

Enforcement

Noncompliance with this regulation may result in the imposition of any of the sanctions

made available in the Colorado statutes pertaining to the business of insurance, or other

laws, which include the imposition of civil penalties, issuance of cease and desist

orders, and/or suspension or revocation of license, subject to the requirements of due

process.

Section 10 Effective Date

The effective date of this regulation is January 1, 2014.

Section 11 History

Originally issued as Colorado Regulation 85-6, effective Oct 1, 1985.

Amended October 1, 1986.

Renumbered as Colorado Regulation 4-2-8, July 1, 1992.

Amended August 1, 1993.

Amended February 1, 1994.

Amended February 1, 2001.

Amended regulation, effective March 2, 2011.

Amended regulation, effective January 1, 2014.

Regulation 4-2-9

CONCERNING NON-DISCRIMINATORY TREATMENT OF

ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) AND HUMAN

IMMUNODEFICIENCY VIRUS (HIV) RELATED ILLNESS BY LIFE AND HEALTH

CARRIERS

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Rules

Section 6

Severability

Section 7

Incorporated Materials

Section 8

Enforcement

Section 9

Effective Date

Section 10

History

Appendix A FDA Licensed/Approved HIV Tests

Section 1

Authority

This amended regulation is promulgated and adopted by the Commissioner of

Insurance under the authority of § § 10-1-109, 10-3-1104.5(3)(d)(II) and 10-3-1110,

C.R.S.

Section 2

Scope and Purpose

The purpose of this regulation is to establish standards that will assure non-

discriminatory treatment with respect to AIDS and HIV infection in underwriting

practices, policy forms and benefit provisions utilized by entities subject to the

provisions of this regulation. It also establishes what HIV/AIDS medical tests, permitted

under § 10-3-1104.5, C.R.S., are considered medically reliable for underwriting

decisions.

Section 3

Applicability

This regulation applies to all entities that provide life or a policy of sickness and accident

insurance in this state including a franchise insurance plan, a fraternal benefit society, a

health maintenance organization, a nonprofit hospital and health service corporation, a

sickness and accident insurance company, a life or annuity company, and any other

entity providing a life policy, annuity, or a policy of sickness and accident insurance

subject to the insurance laws and regulations of Colorado.

Section 4

Definitions

A.

“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S.

B.

“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),

C.R.S.

C.

“Insurance coverage” shall mean life insurance policies, annuities, policies of

sickness and accident insurance, and other coverage that is not a health benefit

plan.

D.

“Person” shall have the same meaning as found at § 10-3-1104.5(2)(f), C.R.S.

E.

“Policy of sickness and accident insurance” shall have the same meaning as

found at §10-16-102(50), C.R.S.

Section 5

Rules

A.

No person, their agent or employee shall make any inquiry or investigation to

determine an insurance applicant's sexual orientation.

B.

Sexual orientation may not be used in the underwriting process or in the

determination of insurability.

C.

Insurance support organizations shall be directed by insurers and carriers to not

investigate, directly or indirectly, the sexual orientation of an applicant or a

beneficiary. All persons shall give written notice to their agents and employees

who conduct investigations of applicants for insurance coverage, that they shall

not investigate, either directly or indirectly, the sexual orientation of an applicant

or beneficiary.

D.

No question shall be used which is designed to establish the sexual orientation of

the applicant.

E.

Questions relating to the applicant having or having been diagnosed as having

AIDS or HIV infection are permissible if they are designed solely to establish the

existence of the condition. For example, straightforward questions on

applications are acceptable, such as, “Have you had or been told by a member of

the medical profession that you have AIDS or HIV infection?” or “Have you

received treatment from a member of the medical profession for AIDS or HIV

infection?” are acceptable.

F.

Questions relating to medical and other factual matters intending to reveal the

possible existence of a medical condition are permissible if they are not used as

a proxy to establish the sexual orientation of the applicant, and the applicant has

been given an opportunity to provide an explanation for any affirmative answers

given in the application. For example: “Have you had chronic cough, significant

weight loss, chronic fatigue, diarrhea, enlarged glands?” These types of

questions should be related to a finite period of time preceding completion of the

application and should be specific. Such questions should provide the applicant

the opportunity to give a detailed explanation.

G.

Persons may not use an applicant's marital status, living arrangements,

occupation, gender, medical history, beneficiary designation, or zip code or other

territorial classification to establish, or aid in establishing, the applicant's sexual

orientation.

H.

For the purpose of rating an applicant for health and life insurance, a person may

impose territorial rates only if the rates are based on sound actuarial principles or

are related to actual or reasonably anticipated experience.

I.

No adverse underwriting decision shall be made because medical records or any

investigation or report indicates that the applicant has demonstrated AIDS or HIV

infection related concerns by seeking counseling from health care professionals.

Neither shall an adverse underwriting decision be made on the basis of such

AIDS or HIV infection related concerns unless a medical test which is a reliable

predictor of infection, as defined in subsection J. of this section, has been

administered. This subsection does not apply to an applicant seeking treatment

and/or diagnosis.

J.

Reliable predictors of infection are delineated in § 10-3-1104.5(3)(d)(I), C.R.S.

Pursuant to § 10-3-1104.5(3)(d)(II), C.R.S., the Commissioner designates the

following tests, approved by the Colorado Department of Public Health and

Environment, as equally reliable predictors of AIDS or HIV infection:

1.

A positive HIV-1 p24 antigen test, as defined by the U.S. Department of

Public Health and Human Services, Center for Disease Control and

Prevention (The Morbidity and Mortality Weekly Report, Volume 95, March

1, 1996).

2.

A positive licensed polymerase chain reaction assay for HIV levels in the

serum.

3.

Two positive or repeatedly reactive commercially licensed serum, oral fluid

or urine ELISA or EIA tests and either:

a.

For serum or oral fluid specimens, a Western Blot test with bands

present at any two of p24, gp41 or gp120/gp160;

b.

for urine specimens, a Western Blot test with bands present at

gp160, or

c.

for serum specimens, a positive HIV 1/2 Multispot test.

K.

To be used for issuing or underwriting a policy, a test described in subsection J.

of this section must have been licensed by the U.S. Food and Drug

Administration as of the effective date of this regulation. A list of such tests is

attached as Appendix A.

L.

If a specific test licensed by the U.S. Food and Drug Administration indicates the

presence of the HIV infection or medical condition indicative of the HIV infection,

the person shall, before relying on a single test result to deny or limit coverage or

to rate the coverage, follow the U.S. Food and Drug Administration confirmation

protocols licensed as of the effective date of this regulation and shall use any

applicable confirmatory tests or series of tests licensed as of the effective date of

this regulation by the U.S. Food and Drug Administration to confirm the

indication. The confirmation protocols and applicable follow-up test regimens are

attached as Appendix A.

M.

If an applicant is required to take an AIDS or HIV infection test in connection with

an application for life or health insurance, the use of such test must be revealed

to the applicant and his or her written consent obtained. Test results shall be

strictly confidential medical information. However, this regulation is not intended

nor should it be interpreted as prohibiting reporting HIV infection to state and

local departments of health as provided in § § 25-4-1402 and 25-4-1403, C.R.S.

N.

Persons subject to this regulation may include questions on applications as to

whether or not the applicant has tested positive on an AIDS or HIV infection test.

However, in the event of an affirmative response, no adverse underwriting

decisions shall be made on the basis of such response unless it can be

determined that the test protocols in subsections J. and K. of this section above,

have been followed.

O.

Insurance coverage which excludes or limits coverages for expenses related to

the treatment of AIDS and HIV related illness or complications of AIDS, e.g.,

opportunistic infection resulting from AIDS, shall not be issued for use in

Colorado, except to the extent that such exclusions or limitations are consistent

with the exclusions or limitations applicable to other covered illnesses or

conditions covered by the policy or certificate.

Section 6

Severability

If any provision of this regulation or the application thereof to any person or

circumstance is for any reason held to be invalid, the remainder of this regulation shall

not be affected.

Section 7

Incorporated Materials

The Morbidity and Mortality Weekly Report, Volume 95, March 1, 1996 published by

U.S. Department of Public Health and Human Services, Center for Disease Control and

Prevention shall mean Morbidity and Mortality Weekly Report, Volume 95, March 1,

1996 as published on the effective date of this regulation and does not include later

amendments to or editions of Morbidity and Mortality Weekly Report, Volume 95, March

1, 1996. A copy of the Morbidity and Mortality Weekly Report, Volume 95, March 1,

1996 may be examined during regular business hours at the Colorado Division of

Insurance, 1560 Broadway, Suite 850, Denver, Colorado, 80202. A certified copy of

Morbidity and Mortality Weekly Report, Volume 95, March 1, 1996 may be requested

from Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333.

A charge for certification or copies may apply.

A copy of the Morbidity and Mortality Weekly Report, Volume 95, March 1, 1996 may be

examined at any state publications depository library.

Section 8

Enforcement

Noncompliance with this regulation may result in the imposition of any of the sanctions

made available in the Colorado statutes pertaining to the business of insurance, or other

laws, which include the imposition of civil penalties, issuance of cease and desist

orders, and/or suspensions or revocation of license, subject to the requirements of due

process.

Section 9

Effective Date

This regulation as amended is effective November 15, 2013.

Section 10 History

Originally issued as Regulation 87-2, effective January 1, 1988.

Renumbered as Regulation 4-2-9, effective June 1, 1992.

Amended Section IV(J), effective February 1, 1995.

Amended Regulation, effective March 2, 1999.

Amended Regulation, effective May 1, 2010.

Amended Regulation, effective July 1, 2012.

Amended Regulation effective November 15, 2013.

Appendix A

FDA Licensed/Approved HIV Tests for Colorado Regulation 4-2-9

Published as of 7/16/2013

Human Immunodeficiency Virus Type 1 (Anti-HIV-1 Assay)

Trade name(s)

(Labeling may be

out of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approval

Date

STN

GS rLAV EIA

HIV-1 EIA

Serum /

Plasma

Donor Screen

(serum/plasm

a). Diagnostic

(Dried blood

spot).

Bio-Rad

Laboratories

Redmond,

WA US

License 1109

6/29/1998 BL102866/1031,

BL102866/1032

Fluorognost HIV-1

IFA

HIV-1 IFA

Serum /

Plasma

Donor

Supplemental.

Donor Screen

(Only in

special

cases).

Sanochemia

Pharmazeutik

a AG Vienna,

Austria US

License 1631

2/5/1992 BL103288/0

Cambridge Biotech

HIV-1 Western Blot

Kit

HIV-1 WB

Serum /

Plasma

Donor

Supplemental.

Diagnostic

supplemental.

Maxim

Biomedical,

Inc. Rockville,

MD US

License 1741

2/25/1999 BL103843

GS HIV-1 Western

Blot

HIV-1 WB

Serum /

Plasma

Donor

Supplemental

Bio-Rad

Laboratories

Redmond,

WA US

License 1109

11/13/199

8

BL103655/0

Trade name(s)

(Labeling may be

out of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approval

Date

STN

Avioq HIV-1

Microelisa System HIV-1 EIA

Serum,

Plasma,

Dried

blood

spot,

Oral

Fluid

Diagnostic:

For the

qualitative

detection of

antibodies to

Human

Immunodefici

ency Virus

Type 1 (HIV-1)

in human

specimens

collected as

serum,

plasma, dried

blood spots,

or oral fluid

specimens

obtained with

OraSure®.HIV

-1 Oral

Specimen

Collection

Device

Avioq Inc.,

Rockville, MD 9/21/2009 BP090022/0

HIVAB HIV-1 EIA HIV-1 EIA

Dried

Blood

Spot

Diagnostic

Abbott

Laboratories

Abbott Park,

IL US License

0043

4/22/1992 BL103404/0

Maxim Biotech

HIV-1 Urine EIA

HIV-1 EIA

Urine

Diagnostic

Maxim

Biomedical,

Inc. Rockville,

MD US

License 1741

1/3/1991 BP000009

Trade name(s)

(Labeling may be

out of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approval

Date

STN

INSTI™ HIV-1

Antibody Test Kit

HIV-1

Rapid

Immuno

assay

Plasma

/ Whole

Blood

(venipu

ncture

and

finger

stick)

Diagnostic:

For the

detection of

antibodies to

Human

Immunodefici

ency Virus

Type 1 (HIV-1)

in human

venipuncture

whole blood,

finger stick

blood, or

plasma

specimens.

bioLytical

Laboratories

Inc. British

Columbia,

Canada V6V

2X7

11/29/201

0

BP090032/0

Reveal Rapid HIV-

1 Antibody Test15 HIV-1

Rapid

Immuno

assay

Serum /

Plasma Diagnostic

MedMira

Laboratories,

Inc. Halifax,

Nova Scotia

Canada B3S

1B3

4/16/2003 BP000023/0

Uni-Gold

Recombigen HIV HIV-1

Rapid

Immuno

assay

Serum /

Plasma

/ Whole

Blood

(venipu

ncture

and

finger

stick)

Diagnostic

Trinity

Biotech, plc

Bray Co.,

Wicklow,

Ireland

12/23/200

3

BP030025/0

Trade name(s)

(Labeling may be

out of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approval

Date

STN

GS HIV-1 Western

Blot

HIV-1 WB

Dried

Blood

Spot

Diagnostic

Supplemental

Bio-Rad

Laboratories

Redmond,

WA US

License 1109

11/13/199

8

BL103655/0

Fluorognost HIV-1

IFA

HIV-1 IFA

Dried

Blood

Spot

Diagnostic

Supplemental

Sanochemia

Pharmazeutik

a AG Vienna,

Austria US

License 1631

5/14/1996 BL103651/0

OraSure HIV-1

Western Blot Kit

HIV-1 WB

Oral

Fluid

Diagnostic

Supplemental

OraSure

Technologies

Bethlehem,

PA

6/3/1996 BP950004/0

Cambridge Biotech

HIV-1 Western Blot

Kit

HIV-1 WB

Urine

Diagnostic

Supplemental

Maxim

Biomedical,

Inc. Rockville,

MD US

License 1741

6/21/2001 BP010009/0

Human Immunodeficiency Virus Type 1 (HIV-1 Nucleic Acid Assay) - see Multiplex

Assays also, below

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

Human

Immunodeficienc

y Virus, Type 1

(HIV-1) Reverse

Transcription

(RT) Polymerase

Chain Reaction

(PCR) Assay

HIV-1 PCR

Plasma

Donor

Screen:

Qualitative

detection of

HIV-1

ribonucleic

acid (RNA) in

pools of

human

Source

Plasma

comprised of

equal aliquots

of not more

than 512

individual

plasma

samples.

BioLife

Plasma

Services,

L.P.

Deerfield, IL

US License

1640

1/31/200

7

BL125100/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

UltraQual HIV-1

RT-PCR Assay

HIV-1 PCR

Plasma

Donor

Screen:

Qualitative

detection of

HIV-1

ribonucleic

acid (RNA) in

pools of

human

Source

Plasma

comprised of

equal aliquots

of not more

than 512

individual

plasma

samples.

National

Genetics

Institute Los

Angeles, CA

US License

1582

9/18/200

1

BL103902/0

COBAS

Ampliscreen HIV-

1 Test

HIV-1 PCR

Plasma/

Cadaveric

serum or

plasma

Donor Screen

Expanded

Indications

For Use:

Source

Plasma

donors, other

living donors,

and organ

donors

Roche

Molecular

Systems,

Inc.

Pleasanton,

CA US

License

1636

12/20/20

02

BL125059/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

APTIMA HIV-1

RNA Qualitative

Assay

HIV-1

HIV-1

Nucleic

Acid

(TMA)

Plasma/

Serum

Diagnostic:

For use as an

aid in

diagnosis of

HIV-1

infection,

including

acute or

primary

infection.

Gen-Probe,

Inc., San

Diego, CA

US License

1592

10/4/200

6

BL103966/504

0

Abbott RealTime

HIV-1

Amplification Kit

HIV-1 PCR

Plasma

Patient

Monitoring:

Quantitation

of Human

Immunodefici

ency Virus

type 1 (HIV-

1) on the

automated

m2000

System. Not

intended to

be used as a

donor

screening test

or as a

diagnostic

test to confirm

the presence

of HIV-1

infection.

ABBOTT

Molecular,

Inc., Des

Plaines, IL

5/11/2007 BP060002/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

Roche Amplicor

HIV-1 Monitor

Test

HIV-1 PCR

Plasma

Patient

Monitoring:

Quantitation

of Human

Immunodefici

ency Virus

Type 1 (HIV-

1) nucleic

acid. Not

intended as a

donor

screening test

or as a

diagnostic

test to confirm

the presence

of HIV-1

infection.

Roche

Molecular

Systems,

Inc.

Pleasanton,

CA US

License

1636

3/2/1999 BP950005/004

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

COBAS

AmpliPrep/COBA

S TaqMan HIV-1

Test

HIV-1 PCR

Plasma

Patient

Monitoring:

Quantitation

of Human

Immunodefici

ency Virus

Type 1 (HIV-

1) nucleic

acid. Not

intended to

be used as a

donor

screening test

or as a

diagnostic

test to confirm

the presence

of HIV-1

infection.

Roche

Molecular

Systems,

Inc.

Pleasanton,

CA US

License

1636

5/11/2007 BP050069/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

Versant HIV-1

RNA 3.0 (bDNA) HIV-1

Signal

amplifi

cation

nucleic

acid

probe

Plasma

Patient

Monitoring:

Quantitation

of Human

Immunodefici

ency Virus

Type 1 (HIV-

1) nucleic

acid. Not

intended to

be used as a

donor

screening test

or as a

diagnostic

test to confirm

the presence

of HIV-1

infection.

Siemens

Healthcare

Diagnostics,

Inc.

9/11/2002 BP000028/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

ViroSeq HIV-1

Genotyping

System with the

3700 Genetic

Analyzer

HIV-1

HIV-1

Genoty

ping

Plasma

Patient

Monitoring:

For detecting

HIV genomic

mutations (in

the protease

and part of

the reverse

transcriptase

regions of

HIV) that

confer

resistance to

specific types

of

antiretroviral

drugs, as an

aid in

monitoring

and treating

HIV infection.

Celera

Diagnostics

Alameda,

CA

6/11/2003 BK030033/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agent

Forma

t

Current

Sample

Use

Manufactur

er

Approval

Date

STN

Trugene HIV-1

Genotyping Kit

and Open Gene

DNA Sequencing

System

HIV-1

HIV-1

Genoty

ping

Plasma

Patient

Monitoring:

For detecting

HIV genomic

mutations (in

the protease

and part of

the reverse

transcriptase

regions of

HIV) that

confer

resistance to

specific types

of

antiretroviral

drugs, as an

aid in

monitoring

and treating

HIV infection.

Siemens

Healthcare

Diagnostics,

Inc.

4/24/200

2

BK020005,

BK090077,

BK080073

Anti-HIV-1 Testing Service

Trade

name(s)

(Labeling

may be

out of

date)

Infec-

tious

Agent

Format Current

Sample

Use

ManufacturerApproval

Date

STN

Home

Access

HIV-1 Test

System

HIV-1

Dried

Blood

Spot

Collection

Device

Dried

Blood

Spot

Diagnostic:

Self-use by

people who

wish to

obtain

anonymous

HIV testing

Home Access

Health Corp.,

Hoffman

Estates, IL

7/22/1996 BP950002/0

Anti-HIV-1 Oral Specimen Collection Device

Trade

name(s)

(Labeling

may be

out of

date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approval

Date

STN

OraSure

HIV-1 Oral

Specimen

Collection

Device

HIV-1

Oral

Specimen

Collection

Device

Oral

Fluid

For Use with

HIV

diagnostic

assays that

have been

approved for

use with this

device.

OraSure

Technologies

Bethlehem,

PA

12/23/1994BP910001/0

Human Immunodeficiency Virus Type 2 (Anti-HIV-2 Assay)

Trade

name(s)

(Labeling

may be out

of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approval

Date

STN

GS HIV-2

EIA

HIV-2 EIA

Serum /

Plasma

Donor

Screen and

diagnostic.

Bio-Rad

Laboratories

Redmond,

WA US

License 1109

4/25/1990BL103227/0

Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay)

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agen

t

Format Current

Sample

Use

Manufactu

rer

Approva

l Date

STN

Abbott HIVAB

HIV-1/HIV-2

(rDNA) EIA

HIV-

1,

HIV-2

EIA

Serum /

Plasma /

Cadaveric

Serum

Donor Screen

and diagnostic

Abbott

Laboratorie

s Abbott

Park, IL US

License

0043

2/14/199

2

BL103385/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agen

t

Format Current

Sample

Use

Manufactu

rer

Approva

l Date

STN

ABBOTT PRISM

HIV O Plus

assay

HIV-

1,

HIV-2

Chemi-

luminesc

ent

Immunoa

ssay

(ChLIA)

Plasma /

Serum/

Cadaveric

Serum

Donor Screen:

Qualitative

detection of

antibodies to

HIV-1 (anti-

HIV-1) groups

M and O

and/or

antibodies to

HIV-2 (anti-

HIV-2) in

human serum

and plasma

specimens.

Organ donor

screening

when

specimens are

obtained while

the donor's

heart is still

beating, in

testing blood

specimens to

screen

cadaveric

(non-heart-

beating)

donors, and as

an aid in the

diagnosis of

HIV- 1 /HIV-2

infection

Abbott

Laboratorie

s Abbott

Park, IL US

License

0043

9/18/200

9

BL125318/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agen

t

Format Current

Sample

Use

Manufactu

rer

Approva

l Date

STN

GS HIV-1/HIV-2

Plus O EIA

HIV-

1,

HIV-2

EIA

Serum /

Plasma /

Cadaveric

Serum

Use with the

Ortho

Summit™

System (OSS)

in the

screening of

blood donors,

also for

diagnostics.

Diagnostic

detection of

antibodies to

HIV-1 (Groups

M and O)

and/or HIV-2 in

human serum,

plasma, and

cadaveric

serum

specimens.

Bio-Rad

Laboratorie

s

Redmond,

WA US

License

1109

8/5/2003

BL125030/0,

BL125030/10,

BL125030/24

ADVIA Centaur

HIV 1/O/2

Enhanced

ReadyPack

Reagents

HIV-

1,

HIV-2

Micropart

icle

Chemi-

luminom

etric

Immunoa

ssay

Plasma/

Serum

Diagnostic: For

qualitative

determination

of antibodies

to the human

immunodeficie

ncy virus type

1, including

Group O,

and/or type 2

in serum or

plasma

Siemens

Healthcare

Diagnostics

, Inc.

5/18/200

6

BP050030/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agen

t

Format Current

Sample

Use

Manufactu

rer

Approva

l Date

STN

Ortho VITROS

HIV-1/HIV-2

HIV-

1,

HIV-2

EIA

Plasma/

Serum

Diagnostic: For

use on the

VITROS®

5600

Integrated and

VITROS®

3600

Immunodiagno

stic Systems

Ortho-

Clinical

Diagnostics

, Inc

Raritan, NJ

US License

1236

3/27/200

8

BP050051/0,

BP050051/18

Multispot HIV-

1/HIV-2 Rapid

Test

HIV-

1,

HIV-2

Rapid

Immunoa

ssay

Plasma /

Serum

Diagnostic

Bio-Rad

Laboratorie

s

Redmond,

WA US

License

1109

11/12/20

04

BP040046/0

SURE CHECK

HIV 1/2 ASSAY

HIV-

1,

HIV-2

Rapid

Immunoa

ssay

Finger

stick &

venous

whole

blood,

serum,

plasma

Diagnostic

Chembio

Diagnostic

Systems,

Inc.

Medford,

NY

5/25/200

6

BP050009/0

HIV 1/2 STAT-

PAK ASSAY

HIV-

1,

HIV-2

Rapid

Immunoa

ssay

Finger

stick &

venous

whole

blood,

serum,

plasma

Diagnostic

Chembio

Diagnostic

Systems,

Inc.

Medford,

NY

5/25/200

6

BP050010/0

Trade name(s)

(Labeling may

be out of date)

Infec-

tious

Agen

t

Format Current

Sample

Use

Manufactu

rer

Approva

l Date

STN

OraQuick

ADVANCE Rapid

HIV-1/2 Antibody

Test

HIV-

1,

HIV-2

Rapid

Immunoa

ssay

Whole

Blood,

Plasma,

Oral Fluid

Diagnostic

OraSure

Technologi

es

Bethlehem,

PA

6/22/200

4

BP010047/16

OraQuick

ADVANCE Rapid

HIV-1/2 Antibody

Test

HIV-

1,

HIV-2

Rapid

Immunoa

ssay

oral fluid,

plasma,

venous

whole

blood

Diagnostic

OraSure

Technologi

es

Bethlehem,

PA

11/7/200

2

BP010047/0

Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay) and Anti-HIV-1

(HIV-1 Antigen Assay)

Trade name(s)

(Labeling may be

out of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufactur

er

Approval

Date

STN

ARCHITECT HIV

Ag/Ab Combo

HIV-1,

HIV-2

Chemi-

lumines

cent

Micropa

rticle

Immuno

assay

(CMIA)

Plasma /

Serum

Diagnostic:

For detection

of antibodies

to HIV-1 and

HIV-2 and

HIV-1 antigen

Abbott

Laboratorie

s Abbott

Park, IL US

License

0043

6/18/2010 BP090080

Bio-Rad GS HIV

Ag/Ab Combo EIA

HIV-1,

HIV-2

EIA

Plasma /

Serum

Diagnostic:

For detection

of antibodies

to HIV-1 and

HIV-2 and

HIV-1 antigen

as an aid in

the diagnosis

of HIV

infection,

including in

pediatric

populations

(children as

young as two

years old).

Bio-Rad

Laboratorie

s Redmond,

WA US

License

1109

7/22/2011 BP100064

Human T-Lymphotropic Virus Types I & II (Anti-HTLV-I/II Assay)

Trade name(s)

(Labeling may be

out of date)

Infec-

tious

Agent

Format Current

Sample

Use

Manufacturer Approv

al Date

STN

Abbott HTLV-I/HTLV-

II EIA

HTLV-1,

HTLV-2 EIA

Serum /

Plasma Donor Screen

Abbott

Laboratories

Abbott Park, IL

US License

0043

8/15/19

97

BL103614/0

ABBOTT PRISM

HTLV-I/HTLV-II

HTLV-1,

HTLV-2

Chemi-

lumines

cent

Immuno

assay

(ChLIA)

Serum /

Plasma

Donor Screen:

Screening test

for individual

human donors,

including

volunteer donors

of whole blood

and blood

components, and

other living

donors for the

presence of anti-

HTLV-I/HTLV-II.

Also intended for

use in testing

blood and

plasma to screen

organ donors

when specimens

are obtained

while the donor’s

heart is still

beating.

Abbott

Laboratories

Abbott Park, IL

US License

0043

1/16/20

08

BL103761/0

Regulation 4-2-10 FILING REQUIREMENTS FOR MULTIPLE EMPLOYER

WELFARE ARRANGEMENTS (MEWAS)

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

Filing Requirements of MEWAs Seeking Exemption Under § 10-3-

903.5(7)(c), C.R.S.

Section 6

Filing Requirements of MEWAs Seeking A Waiver Under § 10-3-

903.5(7)(d), C.R.S

Section 7

Authorized Insurance Arrangements

Section 8

Producer Responsibilities

Section 9

Continuing Compliance

Section 10

Severability

Section 11

Enforcement

Section 12

Effective Date

Section 13

History

Section 1

Authority

This regulation is promulgated and adopted by the Commissioner of Insurance under

the authority of §§ 10-1-109, C.R.S., and 10-3-903.5(7)(d)(V)(A), C.R.S.

Section 2

Scope and Purpose

This regulation is intended to clarify the information to be filed under the provisions of §

10-3-903.5(7)(c), C.R.S., by Multiple Employer Welfare Arrangements (MEWAs)

claiming exempt status from formal licensing requirements. Further, this regulation is

intended to clarify the application requirements under the provisions of § 10-3-

903.5(7)(d) by a MEWA seeking a waiver to operate in Colorado. This regulation also

clarifies the responsibilities of licensed producers with respect to MEWAs.

Section 3

Applicability

This regulation applies to multiple employer welfare arrangements subject to § 10-3–

903.5, C.R.S. For a MEWA seeking an exemption pursuant to § 10-3-903.5(7)(c),

C.R.S, the MEWA must comply with the requirements of Section 5. MEWAs seeking a

waiver pursuant to § 10-3-903.5(7)(d), C.R.S must comply with Section 6.

Section 4

Definitions

A.

“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S.

B.

“Covered lives” mean, for the purposes of this regulation, members, subscribers,

and dependents.

C.

“Fully insured” means, for the purposes of this regulation, an arrangement where

a licensed entity is liable to pay all health care benefits, less any contractual

deductibles, coinsurance or copayments to be made by the covered person. The

liability of the licensed entity for payment of the covered services or benefits is

directly to the individual employee, member or dependent(s) receiving the health

care services or benefits. The contract issuance, claims payment, administration,

and all other insurance related functions remain the ultimate responsibility of the

licensed entity.

D.

“Health plan” means, for the purposes of this regulation, an arrangement such as

a fund, trust, plan, program or other funding mechanism that provides health care

benefits.

E.

“Licensed entity” means, for the purposes of this regulation, a licensed insurance

company; health maintenance organization; or nonprofit hospital, medical-

surgical, and health service corporation having a certificate of authority to

transact business in this state.

F.

“Producer” means, for the purposes of this regulation, a licensed person as

defined by Article 2 of Title 10.

G.

“SERFF” means, for the purposes of this regulation, System for Electronic Rates

and Forms Filing.

H.

“Substantial compliance” means, for the purposes of this regulation, that each

benefit provided to an individual covered by a MEWA complies with the essential

requirements of each mandated benefit.

Section 5

Filing Requirements of MEWAs Seeking Exemption Under § 10-3-

903.5(7)(c), C.R.S.

A.

A filing under this Section 5 is solely for the purpose of providing information

required by the Commissioner to demonstrate a MEWA complies with the

requirements of § 10-3-903.5(7)(c), C.R.S. Determination of compliance or

noncompliance will be provided electronically via SERFF.

B.

The following information must be filed electronically in SERFF in order to meet

the filing requirements of § 10-3- 903.5(7)(c), C.R.S., and for the Commissioner

to make a determination regarding the qualification of a MEWA seeking

exemption from licensure requirements:

1.

Evidence that the MEWA has existed continuously since January 1, 1983.

2.

A copy of the sponsor association's organizational documents,

membership criteria, ownership information and a summary of the

activities and benefits, other than health plan coverage, provided to its

membership.

3.

A copy of the most recent financial report, which includes at a minimum, a

balance sheet, income statement, cash flow report and a detailed listing of

assets, as of the MEWA's most recent fiscal year end. The financial report

must support the required unallocated reserve level of not less than five

percent (5%) of the first two (2) million dollars for annual contributions

made to each arrangement in the preceding fiscal year.

4.

The method of marketing and enrolling eligible participants.

5.

The actuarial information required by § 10-3-903.5(7)(c)(III), C.R.S., that

must be prepared and signed by a qualified actuary. The actuarial

information must include:

a.

An opinion that:

(1)

Is prepared in a format consistent with that required by the

National Association of Insurance Commissioners for

commercial health insurers; and

(2)

Opines on the adequacy of the health plan reserves and

liabilities reflected in the financial report.

b.

A copy of the underlying actuarial report supporting such opinion, in

accordance with the requirements of § 10-7-114, C.R.S., including

all methods and assumptions employed. In addition, the report

must evaluate the adequacy of the contribution and funding levels

of the health plan for the current and immediately subsequent fiscal

year.

6.

A copy of the products offered along with a summary of benefits and a

comparison of how each benefit is in substantial compliance with

Colorado’s mandated benefit provisions.

7.

Such other relevant information as the Commissioner may request in

order to evaluate the qualification status of the MEWA.

8.

A copy of an audited annual financial report within 150 days of the

MEWA's fiscal year end.

C.

Subsections B.1. and B.2. are only required to be filed once, unless materially

altered. B.3. through B.7. must be filed annually within sixty (60) days following

the fiscal year end of the MEWA. Subsection B.8. must be filed annually.

Section 6

Filing Requirements of MEWAs Seeking A Waiver Under § 10-3-

903.5(7)(d), C.R.S.

A.

A MEWA seeking to submit a waiver application to operate in Colorado, as

provided in § 10-3-903.5(7)(d), C.R.S., must comply with this Section 6.

B.

Waiver application requirements.

1.

A MEWA must submit a waiver application to the Division including all

information and documentation outlined in § 10-3- 903.5(7)(d)(I), C.R.S.,

electronically via SERFF.

2.

As part of the application materials, a MEWA seeking a waiver must

demonstrate that it meets Colorado’s minimum solvency requirements as

outlined in Colorado Regulation 2-1-7.

C.

Annual filing requirements. A MEWA that is granted a waiver under § 10-3-

903.5(7)(d), C.R.S., must submit the following information to the Division on an

annual basis electronically via SERFF:

1.

Financial requirements.

a.

Annual financial statements as outlined in Colorado Regulations 3-

1-10 and 3-1-3.

b.

Risk-based capital requirements as outlined in Colorado

Regulations 2-1-7 and 3-1-12.

c.

Annual audited financial report as outlined in Colorado Regulation

3-1-4.

2.

Form filing requirements.

a.

All policy forms associated with the benefits and coverages offered

by the MEWA as outlined in Colorado Regulation 4-2-41.

b.

All marketing materials associated with the benefits and coverages

offered by the MEWA.

3.

Rate filing requirements.

a.

All rates associated with the benefits and coverages offered by the

MEWA as outlined in Colorado Regulation 4-2-39.

b.

For the purposes of rate review, the rates filed by a MEWA granted

a waiver under § 10-3-903.5(7)(d), C.R.S. will be evaluated based

on the number of covered lives with respect to the application of

small group or large group rate filing requirements.

4.

Network adequacy filing requirements.

a.

Information demonstrating compliance with Colorado network

adequacy standards as outlined in Colorado Regulations 4-2-53, 4-

2-54, 4-2-55, and 4-2-56.

Section 7

Authorized Insurance Arrangements

Insurance arrangements that are not subject to licensure as an insurer under Colorado

law are health plans that are:

A.

Fully insured;

B.

Established and maintained by a single employer;

C.

Established and subject to a collectively bargained agreement pursuant to § 10-

3-903.5(7)(b)(II), C.R.S.;

D.

Established by a government entity, pursuant to § 10-3-903.5(7)(b)(I), C.R.S.; or

E.

Determined to be in compliance with § 10-3-903.5(7)(c), C.R.S., and Section 5 of

this regulation.

Insurance arrangements granted a waiver pursuant to § 10-3-903.5(7)(d), C.R.S, and

this Section 6 remain subject to the Division’s full enforcement authority under Title 10,

and the Division may apply to the arrangement any requirements applicable to carriers

as long as the arrangement is operating in Colorado.

Section 8

Producer Responsibilities

No producer may solicit, advertise, market, accept an application, or place coverage for

a person who resides in this state with a MEWA unless the producer first verifies that

the MEWA complies with the requirements of this regulation and the provisions of § 10-

3-903.5(7), C.R.S. This is accomplished by the producer acquiring a copy of the

Division's correspondence determining that the MEWA is in compliance with this

regulation and the provisions of § 10-3-903.5(7)(c), C.R.S.

Lack of knowledge regarding the compliance of any organization or health plan is not a

defense to a violation of this regulation. Any producer involved in the solicitation or sale

of health plans through unauthorized insurers or MEWAs which are found not to be in

compliance with the provisions of § 10-3- 903.5(7), C.R.S. and this regulation are

subject to discipline or action including fines, suspension or revocation of his or her

license.

Section 9

Continuing Compliance

In the event that a MEWA ceases to qualify under Section 5 of this regulation, it will be

transacting the business of insurance in the State of Colorado without a license and

subject to the procedures of Parts 9 and 10 of Article 3 of Title 10, C.R.S., and the

provisions of the State Administrative Procedure Act, Part 4 of Title 24, C.R.S., as

applicable.

In the event a MEWA ceases to qualify for a waiver under Section 6, it will be

transacting the business of insurance in Colorado unlawfully and subject to the

procedures of Parts 9 and 10 of Article 3 of Title 10, C.R.S., and the provisions of the

State Administrative Procedure Act, Part 4 of Title 24, C.R.S., as applicable.

Section 10 Severability

If any provision of this regulation or the application of it to any person or circumstance is

for any reason held to be invalid, the remainder of this regulation shall not be affected.

Section 11 Enforcement

Noncompliance with this regulation may result in the imposition of any sanctions made

available in the Colorado statutes pertaining to the business of insurance, or other laws,

which include the imposition of civil penalties, issuance or cease and desist orders,

and/or suspensions or revocations of license, subject to the requirements of due

process.

Section 12 Effective Date

This amended regulation shall be effective May 30, 2022.

Section 13 History

Regulation 4-2-10, effective July 1, 1994

Amended regulation effective October 2, 2006

Amended regulation effective August 1, 2012

Amended regulation effective September 1, 2017

Amended regulation effective May 30, 2022

Regulation 4-2-11 RATE FILING SUBMISSIONS FOR LIMITED BENEFIT HEALTH

INSURANCE PLANS, EXCESS/STOP LOSS INSURANCE, LONG-TERM CARE

INSURANCE, MEDICARE SUPPLEMENT INSURANCE, SICKNESS AND ACCIDENT

INSURANCE, DISABILITY INCOME, DENTAL, OTHER THAN HEALTH BENEFIT

PLANS

Section 1

Authority

Section 2

Scope and Purpose

Section 3

Applicability

Section 4

Definitions

Section 5

General Rate Filing Requirements

Section 6

Actuarial Memorandum

Section 7

Additional Rate Filing Requirements for Long-term Care Insurance

Section 8

Additional Rate Filing Requirements for Medicare Supplement Policies

Section 9

Additional Rate Filing Requirements by Line of Business and by Market

Type

Section 10

Prohibited Rating Practices

Section 11

Wellness Benefit Requirements

Section 12

Severability

Section 13

Incorporation by Reference

Section 14

Enforcement

Section 15

Effective Date

Section 16

History

Appendix A: Determination of Credibility Weights in Case of Nationwide Experience Not

Reaching Full Credibility in the Most Recent 3 Years

Section 1

Authority

This regulation is promulgated and adopted by the Commissioner of Insurance under

the authority of §§ 10-1-109, 10-3-1110, 10-16-107, 10-16-109, 10-18-105(2), and 10-

19-113.7, C.R.S.

Section 2

Scope and Purpose

The purpose of this regulation is to ensure that health insurance rates on limited benefit

plans, excess/stop loss Insurance, sickness and accident insurance, disability income,

and other than health benefit plans, are not excessive, inadequate or unfairly

discriminatory, by establishing the requirements for rate filings.

Section 3

Applicability

This regulation applies to all carriers offering certain types of limited benefit insurance,

as found at § 10-16-102(32)(b), C.R.S., and including, but not limited to the following

types of coverage: dental, including dental coverage plans (except for plans covering

pediatric dental as an essential health benefit), long-term care, disability income

insurance, paid family and medical leave insurance, , Medicare supplement, prepaid

dental, supplemental health, travel accident/sickness, vision, and excess/stop loss

carriers for employers with self-insured health plans, and any other type of insurance

that does not meet the definition of a health benefit plan. This regulation does not apply

to short-term limited duration health insurance policies.

Section 4

Definitions

A.

“1990 Standardized Medicare supplement benefit plan” or “1990 plan” mean, for

the purposes of this regulation, a group or individual policy of Medicare

supplement insurance issued on or after May 1, 1992 and prior to June 1, 2010,

and includes Medicare supplement insurance policies and certificates renewed

on or after April 30, 1992 which are not replaced by the issuer at the request of

the insured.

B.

“2010 Standardized Medicare supplement benefit plan,” “2010 standardized

benefit plan,” or “2010 plan” mean, for the purposes of this regulation, a group or

individual policy of Medicare supplement insurance issued with an effective date

for coverage issued on or after June 1, 2010.

C.

“Accident-only policy” means, for the purposes of this regulation, coverage for

death, dismemberment, disability, and/or hospital and medical care caused by or

necessitated as the result of an accident or specified kinds of accident.

D.

“Accidental death and dismemberment coverage” means, for the purposes of this

regulation, an insurance policy that pays “stated benefits” in the event of death or

dismemberment caused by an accident. Medical care, disability income or other

coverages, such as hospitalization, outpatient surgery, other injury benefits, or

non-health coverages, shall be filed under the appropriate line of business for the

product.

E.

“Actuarial Memorandum” means, for the purposes of this regulation, the required

4-2-11 Rate Filing spreadsheet. The actuarial memorandum is the same as the

Regulation 4-2-11 Excel Template spreadsheet available in SERFF.

F

“Annual renewable term” means, for the purposes of this regulation, a policy that

provides insurance coverage for one year and allows the insured to continue

coverage under the policy without new evidence of insurability.

G.

“Benefits ratio” shall have the same meaning as found at § 10-16-102(5), C.R.S.

H.

“Blanket accident policy” means, for the purposes of this regulation,

supplemental limited benefit expense policy providing supplemental medical

benefits for accident-related medical losses. Benefits do not exceed a stated

dollar amount per day, per month. Requirements are included in Section 6.C. of

this regulation.

I.

“Blanket accident and sickness policy” means, for the purposes of this regulation,

supplemental health limited benefit expense policy providing medical benefits for

sickness-related or accident-related medical losses. Benefits are not to exceed a

stated dollar amount per day, per month. Requirements are included in Section

6.C. of this regulation.

J.

“Blanket sickness policy” means, for the purposes of this regulation, a

supplemental health limited benefit expense policy providing supplemental

medical benefits for sickness related medical losses. Requirements are included

in Section 6.C. of this regulation.

K.

“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S. and

for the purposes of this regulation, shall also include issuers of Medicare

supplement policies.

L.

“Coordination of benefits” (COB) means, for the purposes of this regulation, a

provision establishing an order in which policies pay the claims and permitting

secondary policies to reduce the benefits so that the combined benefits of all

plans do not exceed the total allowable expenses. Requirements are included in

Section 6.C.

M.

“Covered lives” means, for the purposes of this regulation, the number of

members, subscribers and dependents.

N.

“Credibility” means, for the purposes of this regulation, the degree of accuracy in

predicting future events based on statistical reporting of past events. It is also a

measure of the predictive value an actuary attaches to a particular set of data.

1.

“Complement of credibility” means, for the purposes of this regulation,

related experience to supplement data that is not fully credible.

Complement of credibility is calculated as 1 – credibility.

2.

“Fully credible experience” means, for the purposes of this regulation, at

least 2000 life years and 2000 claims.

O.

“Dental coverage plan” shall have the same meaning as found at § 10-16-

165(1)(b), C.R.S.

P.

“Disability income policy” means, for the purposes of this regulation, a policy that

provides periodic payments to replace income lost when the insured is unable to

work as a result of a sickness or injury.

Q.

“Disabled Life Reserves” means, for the purposes of this regulation, the present

value of all future expected payments for known and open claims that were

incurred prior to the financial statement date (i.e., present value of amounts not

yet due).

R.

“Dividends” mean, for the purposes of this regulation, both policyholder and

stockholder dividends.

S.

“Effective date requested” means, for the purposes of this regulation, the specific

date that the filed or approved rates can be charged to an individual or group.

T.

“Excessive” means, for the purposes of this regulation, rates that are likely to

produce a long run profit that is unreasonably high for the insurance provided or

if the rates include a provision for expenses that is unreasonably high in relation

to the services rendered. In determining if the rate is excessive, the

Commissioner may consider profits, dividends, annual rate reports, annual

financial statements, subrogation funds credited, investment income or losses,

unearned premium reserve, reserve for losses, surpluses, executive salaries,

expected benefits ratios, and any other appropriate actuarial factor as

determined by accepted actuarial standards of practice. The Commissioner may

require the submission of additional relevant information deemed necessary in

determining whether to reject, approve or disapprove a rate filing.

U.

“File and Use” means, for the purposes of this regulation, a filing procedure that

does not require approval by the Commissioner prior to distribution, release to

producers, collection of premium, advertising, or any other use of the rate.

V.

“Filing date” means, for the purposes of this regulation, the date the rate filing is

received at the Division.

W.

“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),

C.R.S.

X.

“Health care services” shall have the same meaning as found at § 10-16-102(33),

C.R.S.

Y.

“Health coverage plan” shall have the same meaning as found at § 10-16-

102(34), C.R.S. For purposes of this regulation, this definition shall not include

health benefit plans.

Z.

“Hospital indemnity coverage” means, for the purposes of this regulation,

supplemental coverage that provides a stated daily, weekly or monthly payment

while the insured is hospitalized, regardless of expenses incurred and regardless

of whether or not other insurance is in force.

AA.

“If-known” means, for the purposes of this regulation, the premium that would

have been charged from the time of issue if the carrier could have predicted that

the experience would develop as it has and the current assumptions were the

original pricing assumptions discounted using maximum statutory valuation rates.

AB.

“Inadequate” means, for the purposes of this regulation, rates that are insufficient

to sustain projected losses and expenses, or if the use of such rates, if

continued, will tend to create a monopoly in the marketplace. In determining if the

rate is inadequate, the Commissioner may consider profits, dividends, annual

rate reports, annual financial statements, subrogation funds credited, investment

income or losses, unearned premium reserve, reserve for losses, surpluses,

executive salaries, expected benefits ratios, and any other appropriate actuarial

factors as determined by accepted actuarial standards of practice. The

Commissioner may require the submission of additional relevant information

deemed necessary in determining whether to approve or disapprove a rate filing.

AC.

“Inadequate rates” means, for the purposes of this regulation, rates that are

clearly insufficient to sustain projected losses and expenses, or if the use of such

rates, if continued, will tend to create a monopoly in the marketplace. In

determining if the rate is inadequate, the Commissioner may consider profits,

dividends, annual rate reports, annual financial statements, subrogation funds

credited, investment income or losses, unearned premium reserve, reserve for

losses, surpluses, executive salaries, expected benefits ratios, and any other

appropriate actuarial factors as determined by accepted actuarial standards of

practice. The Commissioner may require the submission of whatever relevant

information the Commissioner deems necessary in determining whether to

approve or disapprove a rate filing.

AD.

“Incurred But Not Reported liabilities” or “IBNR liabilities” means, for the

purposes of this regulation, the present value of all future expected payments for

unknown open claims that were incurred prior to the financial statement date, but

not yet reported as of that date. Applies to both short and long term products.

AE.

“Indemnity policy” means, for the purposes of this regulation, coverage that

provides benefits based on an event incurred and pays a flat, fixed dollar amount

rather than expenses incurred on a medical expense basis.

AF.

“Insurance trend” means, for the purposes of this regulation, the combined effect

of any other items impacting medical trend, including the impact on trend due to

anticipated demographic changes. Insurance trend includes anti-selection

resulting from rate increases and discontinuance of new sales.

AG.

“Lifetime loss ratio” means, for the purposes of this regulation:

1.

The sum of the accumulated value of policy benefits from the inception of

the policy form(s) to the end of the experience period and the present

value of expected policy benefits over the entire future period for which the

proposed rates are expected to provide coverage; divided by:

2.

The sum of the accumulated value of earned premiums from the inception

of the policy form(s) to the end of the experience period and the present

value of expected earned premium over the entire future period for which

the proposed rates are expected to provide coverage.

Active life reserves do not represent claim payments, but provide for

timing differences. Therefore, active life reserves shall not be included in

this calculation. An appropriate interest rate should be used to calculate

the accumulated values and the present values of incurred losses and

earned premiums. If the statutory valuation rate is not used, the carrier

should explain why using a different discount rate is more appropriate.

AH.

“Lifetime loss ratio standard” means, for the purposes of this regulation, any

policy form or forms for which the benefits ratio in any policy duration is expected

to vary from the lifetime loss ratio.

AI.

“Limited benefit health coverage” means, for the purposes of this regulation, any

type of health coverage that is not provided by a health benefit plan, as found at

§ 10-16-102(32)(a), C.R.S.

AJ.

“Medical trend” means, for the purposes of this regulation, the combined effect of

medical provider price increases, utilization changes, medical cost shifting, new

medical procedures and technology, and other insurance trend. Medical trend

includes changes in unit costs of medical services or procedures, medical

provider price changes, changes in utilization (other than due to advancing age),

medical cost shifting, and new medical procedures and technology.

AK.

“New policy form or product” means, for the purposes of this regulation, a policy

form that has “substantially different new benefits” or unique characteristics

associated with risk or cost that are different from existing policy forms offered by

the company. For example, a guaranteed issue policy form is different from an

underwritten policy form, a managed care policy form is different from a non-

managed care policy form, and a direct written policy form is different from a

policy sold using producers, etc.

AL.

“Non-cancellable” means, for the purposes of this regulation, a policy which the

insured has the right to continue in force by the timely payment of premiums set

forth in the policy, during which period the insurer has no right to make

unilaterally any change in any provision of the policy while the policy is in force.

AM.

“On-rate level premium” means, for the purposes of this regulation, the premium

that would have been generated if the present rates had been in effect during the

entire period under consideration.

AN.

“Paid family and medical leave insurance” means, for the purposes of this

regulation, providing partial wage-replacement benefits to an eligible individual

who takes leave from work to care for a new child or a family member with a

serious health condition or who is unable to work due to the individual's own

serious health condition or when the individual or the individual’s family member

is a victim of domestic violence, stalking, or sexual assault or circumstances

related to a family member’s active duty military service.

AO.

“Plan” means, for the purposes of this regulation, the specific benefits and cost-

sharing provisions available to a covered person.

AP.

“Premium” shall have the same meaning as found at § 10-16-102(51), C.R.S.

AQ.

“Product(s)” means, for the purposes of this regulation, the services covered as a

package under a policy form by a carrier, which may have several cost-sharing

options and riders as options.

AR.

“Qualified actuary” means, for the purposes of this regulation, a member of the

American Academy of Actuaries or a person who has demonstrated to the

satisfaction of the Commissioner that the person has sufficient educational

background and who has no less than seven (7) years of recent actuarial

experience relevant to the area of qualifications, as defined in Colorado

Insurance Regulation 1-1-1.

AS.

“Rate” means, for purposes of this regulation, the amount of money a carrier

charges as a condition of providing health care coverage. The rate charged

normally reflects such factors as the carrier’s expectation of the insured’s future

claim costs, the insured’s share of the carrier’s claim settlement, operational and

administrative expenses, and the cost of capital. This amount is net of any

adjustments, discounts, allowances or other inducements permitted by the

contract.

AT.

“Rate filing(s)” means, for the purposes of this regulation, a filing(s) that contains

all of the items required in this regulation including the proposed base rates and

all rating factors, the underlying rating assumptions, support for new product

offerings and all changes in existing rates, factors and assumptions utilized,

including the continued use of trend factors.

AU.

“Rate increase” shall have the same meaning as found at § 10-16-102(57),

C.R.S., and, for the purposes of this regulation, includes increases in any current

rate or any factor, including trend factors, used to calculate premium rates for

new or existing policyholders, members or certificate holders.

AV.

“Rating period” shall have the same meaning as found at § 10-16-102(58),

C.R.S.

AW.

“Renewed” means, for the purposes of this regulation, a plan renewed upon the

occurrence of the earliest of the annual anniversary date of issue; the date on

which premium rates can be or are changed according to the terms of the plan;

or the date on which benefits can be or are changed according to the terms of

the plan. If the plan specifically allows for a change in premiums or benefits due

to changes in state or federal requirements and a change in the health coverage

plan premiums or benefits due solely to changes in state or federal requirements

are not considered a renewal in the health care coverage contract, then such a

change will not be considered a renewal for the purposes of this regulation.

AX.

“Retention” means, for the purposes of this regulation, the sum of all non-claim

expenses including investment income from unearned premium reserves,

contract or policy reserves, reserves from incurred losses, and reserves from

incurred but not reported losses as a percentage of total premium (or 100%

minus the lifetime loss ratio for products priced on a lifetime loss ratio standard).

AY.

“Review and Approval” means, for the purposes of this regulation, a filing

procedure that requires a rate change to be affirmatively approved by the

Commissioner prior to distribution, release to producers, collection of premium,

advertising, or any other use of the rate.

AZ.

“Sickness only policy” means, for the purposes of this regulation, limited benefit

expense coverage that only covers illness and disease and does not cover any

accidents.

BA.

“Specified disease policy” means, for the purposes of this regulation, payment of

benefits for the diagnosis and treatment of a specifically named disease or

diseases. Medical conditions resulting from accidents are not diseases and shall

not be included.

BB.

“SERFF” means, for the purposes of this regulation, System for Electronic Rate

and Form Filing.

BC.

“Travel insurance” means, for the purposes of this regulation, limited benefit

expense coverage providing medical benefits for losses incurred while traveling

generally outside a 100-mile radius of the US borders but may extend to

domestic as well as foreign travel. The policy may provide both sickness and

injury benefits, and air transportation services for medically necessary

emergencies.

BD.

“Trend” means, for the purposes of this regulation, any procedure for projecting

losses to the average date of loss, or of projecting premiums or exposures to the

average date of writing. Trend used solely for restating historical experience from

the experience period to the rating period, or which is used to project morbidity, is

considered a rating assumption.

BE.

“Trend factors” means, for purposes of this regulation, rates or rating factors that

vary over time or due to the duration that the insured has been covered under the

policy or certificate, and which reflect any of the components of medical or

insurance trend assumptions used in pricing.

BF.

“Unfairly discriminatory rates” means, for the purposes of this regulation,

charging different rates for the same benefits provided to individuals or groups,

with like expectations of loss; or if after allowing for practical limitations,

differences in rates which fail to equitably reflect the differences in expected

losses and expenses. A rate is not unfairly discriminatory solely if different

premiums result for policyholders with like loss exposures but different expenses,

or like expenses but different loss exposures, so long as the rate reflects the

differences with reasonable accuracy.

BG.

“Use of the rates” means, for the purposes of this regulation, the distribution of

rates or factors to calculate the premium amount for a specific policy or certificate

holder including advertising, distributing rates or premiums to producers, and

disclosing premium quotes. It does not include releasing information about the

proposed rating change to other government entities or disclosing general

information about the rate change to the public.

BH.

“Valid group” means, for the purposes of this regulation, a group that meets the

requirements as found in § 10-16-214(1), C.R.S.

BI.

“Wellness benefits” means, for the purposes of this regulation, health benefits

offered outside of the specifically defined line of coverage, such as annual

preventive care and health screening, including laboratory services, x-ray

services and similar services.

Section 5

General Rate and Dental Loss Ratio Filing Requirements

A.

Rate Filings except for Medicare supplement and Dental

1.

New Products

All New Product Filings are considered File & Use. Carriers must submit

rate filings to the Division prior to usage.

2.

Existing Products

a.

Any existing product without any Colorado policyholder receiving a

rate increase is considered File & Use.

b.

If any Colorado policyholder is projected to receive an increase, the

filing is considered Review & Approval.

B.

Medicare supplement Rate Filings

1.

All Medicare supplement filings are filed as Review & Approval.

2.

Medicare supplement carriers shall not use the r

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.